










 




Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version























DP VIII ASSOCIATES, L.P. Insider Insider Trades - NASDAQ.com



























































Hot Topics:
ETFs |
Smart Portfolio |
Currencies |
Online Broker Center















Search






















Home > 
    Quotes > 
    Ownership & Insider Trades > 
    Individual Insiders






Insider Trades of DP VIII ASSOCIATES, L.P.





Click on the column header to resort ascending (▲) or descending (▼).



Individual Insider Trades



Company


Relation


Last Date ▼


Type


Tran


OwnerType


Shares Traded


Last Price


Shares Held



SYNDAX PHARMACEUTICALS INC
Beneficial Owner (10%)
03/08/2016
Form 4
Acquisition (Non Open Market)
direct
5,641
0
5,641















Highest Rated Articles of Last Week



Shareholders Approve Major Structural Change to Top Performing...
Yatra Attains Leadership Position in Corporate Travel With the...
Miller Heiman Group Selects CallidusCloud Datahug for Pipeline...
Tractor Supply Company Reports Second Quarter Results
Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon





View All Highest Rated































Most Rated Stocks of Last Week
Rated stocks for NASDAQ, NYSE and AMEX

Symbol  /  Ratings Consensus

AAPL

86% bullish
                    of
                    2911
                    ratings
Rate It


FB

76% bullish
                    of
                    1327
                    ratings
Rate It


MSFT

84% bullish
                    of
                    649
                    ratings
Rate It


TSLA

78% bullish
                    of
                    587
                    ratings
Rate It


GOOG

91% bullish
                    of
                    128
                    ratings
Rate It


JPM

70% bullish
                    of
                    88
                    ratings
Rate It


GM

68% bullish
                    of
                    80
                    ratings
Rate It


NVDA

82% bullish
                    of
                    131
                    ratings
Rate It


BAC

75% bullish
                    of
                    474
                    ratings
Rate It


INTC

83% bullish
                    of
                    266
                    ratings
Rate It


More Most Rated Stocks



























CLOSEX

Edit Favorites

Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.






Update

Clear List







CLOSEX
Customize your NASDAQ.com experience
Background Color Selector

Select the background color of your choice:





 Black
							





 Slate Gray
							






 Light Gray
							





 Gray Blue
							






Quote Search

Select a default target page for your quote search:



						 Real-Time

						 After Hours

						 Pre-Market
 News
					


						 Flash Quote

						 Summary Quote

						 Interactive Charts

						 Default Setting




					Please note that once you make your selection, it will apply to all future visits to NASDAQ.com.
					If, at any time, you are interested in reverting to our default settings, please select Default Setting above.
					
					If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com.
				





CLOSEX
Please confirm your selection:

					You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings?


YES
NO













CLOSEX


Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.





CLOSEX






































DP VII ASSOCIATES LP Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      DP VII ASSOCIATES LP
                    

•   PRINCETON, NJ
                      
How do I update this listing?




                                             DP VII Associates is based out of Princeton.    WhaleWisdom has at least 21 insider transactions (Form 3,4,5) in our database for DP VII Associates. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from DP VII ASSOCIATES LP, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




dp vii associates lp


ONE PALMER SQ

PRINCETON
NJ
                                                        
                                                    08542


                                                      Business Phone:
                                                      8584361400
SEC SIC CODE:2834-PHARMACEUTICAL PREPARATIONS







Recent SEC Filings




4 filed on 11/03/2016
4 filed on 10/14/2016
3 filed on 10/05/2016
4 filed on 05/27/2016
4 filed on 04/27/2016
4 filed on 04/21/2016
4 filed on 04/13/2016
4 filed on 04/08/2016
4 filed on 08/20/2015
3 filed on 05/06/2015
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free




















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft











DP VII ASSOCIATES LP - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











DP VII ASSOCIATES LP
Check out list of companies and businesses related to DP VII ASSOCIATES LP. Find out DP VII ASSOCIATES LP address and contact details. View other people related to DP VII ASSOCIATES LP - coworkers, colleagues, companions, etc.
Address:   

C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE PRINCETON 08542 NJ




Companies related to DP VII ASSOCIATES LP
CIKCompany NamePositionCompany Address0001301501Achaogen Inc10% Owner 7000 SHORELINE COURT SUITE 371 SOUTH SAN FRANCISCO 940800001311596Tobira Therapeutics, Inc.10% Owner 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO 940800001333248CADENCE PHARMACEUTICALS INC10% Owner 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO 921300001375151ZOGENIX, INC.10% Owner 5858 HORTON STREET, #455  EMERYVILLE 946080001382911Orexigen Therapeutics, Inc.10% Owner 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA 920370001403708Evoke Pharma Inc10% Owner 420 STEVENS AVENUE SUITE 370 SOLANA BEACH 920750001427570OBALON THERAPEUTICS INC10% Owner 5421 AVENIDA ENCINAS SUITE F San Diego 920080001434868Esperion Therapeutics, Inc.10% Owner 3891 RANCHERO DRIVE, SUITE 150  ANN ARBOR 481080001438133TANDEM DIABETES CARE INC10% Owner 11045 ROSELLE STREET SUITE 200 San Diego 921210001466301Clovis Oncology, Inc.10% Owner 5500 FLATIRON PARKWAY SUITE 100 BOULDER 803010001618835Neothetics, Inc.10% Owner 9171 TOWNE CENTRE DRIVE, SUITE 270  SAN DIEGO 92122




DP VII ASSOCIATES LP on the Web
Persons related to DP VII ASSOCIATES LP - Achaogen IncNamePositionCityColowick  AlanSouth San FranciscoColowick  AlanSouth San FranciscoARCH VENTURE FUND VI LP10% Owner CHICAGOARCH VENTURE PARTNERS VI LLCCHICAGOARCH VENTURE PARTNERS VI LPCHICAGOPETER J  BARRIS10% Owner BALTIMOREFOREST  BASKETT10% Owner BALTIMOREFilice  BeckiSouth San FranciscoKaren  BernsteinDirector FORT WASHINGTONDEREK A  BERTOCCIChief Financial Officer DEREK A  BERTOCCISVP and CFO SOUTH SAN FRANCISCOJAMES C  BLAIR10% Owner PRINCETONWise  BlakeSouth San FranciscoWise  BlakeSouth San FranciscoCHRISTOPHER S.  BOERNERDirector SOUTH SAN FRANCISCORoberts  BryanSouth San FranciscoROBERTS  BRYANPALO ALTORoberts  BryanSouth San FranciscoCLINTON  BYBEECHICAGOSamuels  CamilleMenlo ParkSamuels  CamilleSouth San FranciscoWelch  ChristineSouth San FranciscoWalsh  ChristopherSouth San FranciscoWalsh  ChristopherSouth San FranciscoAlan  ColowickDirector REDWOOD CITYKEITH  CRANDELLCHICAGOHom  DennisSouth San FranciscoDOMAIN PARTERS VII L P10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONJOHN C  DOYLEDirector SOUTH SAN FRANCISCOJOHN C  DOYLEDirector SOUTH SAN FRANCISCOBecki  FiliceSOUTH SAN FRANCISCOMichael  FischbachDirector SOUTH SAN FRANCISCOAnthony A. Jr.  Florence10% Owner CHEVY CHASEIan  FriedlandSVP, Chief Medical Officer SOUTH SAN FRANCISCOLoeb  GarySouth San FranciscoHalley E  GilbertDirector CAMBRIDGEStea  GregorySouth San FranciscoStea  GregorySouth San FranciscoGrowth Equity Opportunities IV, LLC10% Owner TIMONIUMBrian K  Halak10% Owner PRINCETONGilbert  HalleySouth San FranciscoMoser  HeinzSouth San FranciscoKenneth  HillanChief Executive Officer SOUTH SAN FRANCISCODennis  HomSOUTH SAN FRANCISCOFriedland  IanSouth San FranciscoKevin  Judice  J.South San FranciscoDoyle  JohnSouth San FranciscoDoyle  JohnSouth San FranciscoDoyle  JohnSouth San FranciscoHollway  JohnSouth San FranciscoSmither  JohnSouth San FranciscoSmither  JohnSouth San FranciscoBruss  JonSouth San FranciscoHillan  KennethSouth San FranciscoHillan  KennethSouth San FranciscoNussbacher  KennethSouth San FranciscoLieginger  KentSouth San FranciscoLieginger  KentSouth San FranciscoKRISHNA KITTU  KOLLURI10% Owner BALTIMORESwem  LeeSouth San FranciscoKent  LiegingerDirector SOUTH SAN FRANCISCOGARY  LOEBGeneral Counsel EMERYVILLEJOSHUA  MAKOWER10% Owner Fischbach  MichaelSouth San FranciscoFischbach  MichaelSouth San FranciscoDAVID M  MOTT10% Owner GAITHERSBURGChristine  MurrayVP, Regulatory Affairs SOUTH SAN FRANCISCONEA 15 GP, LLCTIMONIUMNEA Partners 15, L.P.TIMONIUMROBERT  NELSENCHICAGONew Enterprise Associates 15, L.P.TIMONIUMMore  RobertSouth San FranciscoMore  RobertPalo AltoBRYAN E  ROBERTSDirector MENLO PARKBRYAN E  ROBERTSDirector PALO ALTOSCOTT M  ROCKLAGEDirector SOUTH SAN FRANCISCOJon  Sakoda10% Owner TIMONIUMCamille D  SamuelsDirector SOUTH SAN FRANCISCOSCOTT D  SANDELL10% Owner BALTIMOREZeryn  SarpangalSee Remarks SOUTH SAN FRANCISCOTobin  SchilkeChief Financial Officer SOUTH SAN FRANCISCOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONRocklage  ScottSouth San FranciscoRocklage  ScottMenlo ParkJohn W  SmitherDirector CALABASASJohn W  SmitherDirector SOUTH SAN FRANCISCOPeter W.  Sonsini10% Owner MENLO PARKGREGORY  STEADirector LEXINGTONLee  SwemSOUTH SAN FRANCISCOKing  ThomasSouth San FranciscoSchilke  TobinSouth San FranciscoJESSE I  TREU10% Owner PRINCETONCox  TroySouth San FranciscocVEF Management IV, LLCPALO ALTOVENROCK ASSOCIATES IV L P10% Owner PALO ALTOVENROCK ENTREPRENEURS FUND IV L PPALO ALTOVenrock Management IV, LLCPALO ALTOVenrock Partners, L.P.PALO ALTOVenrock Partners Management, LLCPALO ALTOVersant Affiliates Fund II-A, LPMENLO PARKVersant Side Fund II, LPMENLO PARKVersant Venture Capital II, LPMENLO PARKVersant Ventures II LLC10% Owner MENLO PARKRavi  Viswanathan10% Owner TIMONIUMNICOLE  VITULLO10% Owner PRINCETONCHRISTOPHER T PHD  WALSHDirector LEXINGTONCHRISTOPHER T PHD  WALSHDirector SOUTH SAN FRANCISCOWELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST10% Owner LONDONHarry R  WellerBALTIMOREBlake  WiseSee Remarks SOUTH SAN FRANCISCOSarpangal  ZerynSouth San FranciscoPersons related to DP VII ASSOCIATES LP - Tobira Therapeutics, Inc.NamePositionCityplc  ActavisPARSIPPANYAllergan Holdco US, Inc.IRVINEGopka  AntonBasking RidgeClark  B.Basking Ridge3, FCPR  BIODISCOVERY10% Owner PARISBIOTECHNOLOGY VALUE FUND II LPCHICAGOBIOTECHNOLOGY VALUE FUND L PCHICAGOBIOTECHNOLOGY VALUE FUND L PCHICAGOJAMES C  BLAIR10% Owner PRINCETONCarol L  BrosgartDirector SOUTH SAN FRANCISCOBVF INC/ILCHICAGOBVF PARTNERS L P/IL CHICAGOCourts  ChrisBasking RidgeB. Jefferson  ClarkDirector BASKING RIDGEB. Jefferson  ClarkDirector BASKING RIDGEB. Jefferson  ClarkDirector BASKING RIDGEJeffrey H  CooperDirector NOVATOChristopher  CourtsVice President of Finance BASKING RIDGEChristopher  CourtsVice President of Finance BASKING RIDGEMazzo  DavidBasking RidgePodlesak  DennisBasking RidgeASSOCIATES  DOMAIN10% Owner PRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEYBRIAN H  DOVEY10% Owner PRINCETONDP VI Associates, L.P.10% Owner PRINCETONDe Rothschild Investment Partners  EdmondPARISR Don  ElseySr. VP/Chief Financial Officer BASKING RIDGER Don  ElseySr. VP/Chief Financial Officer BASKING RIDGELaurent  FischerChief Executive Officer WATERTOWNFrazier Healthcare V, LP10% Owner SEATTLEAndrew J.  FromkinDirector BASKING RIDGEAndrew J.  FromkinDirector BASKING RIDGEDrew J  FromkinDirector NEWTONAlexander R  GiaquintoCCO and SVP of Reg. Affairs BASKING RIDGEAlexander R  GiaquintoCCO, SVP of Reg. Affairs BASKING RIDGEAnton  GopkaDirector BASKING RIDGEAnton  GopkaDirector BASKING RIDGEAnton  GopkaDirector BASKING RIDGEBrian K  HalakPRINCETONPatrick J  HeronDirector PALO ALTOClark  JeffBasking RidgeHelen  JenkinsChief Operating Officer SOUTH SAN FRANCISCOTreu  JesseBasking RidgeKim P.  KamdarPRINCETONROBERT A  KIERLIN10% Owner WINONAROBERT A  KIERLIN10% Owner WINONAMARK N  LAMPERTSAN FRANCISCOEric  LefebvreChief Medical Officer SOUTH SAN FRANCISCOPierre  LegaultDirector BERKELEY HEIGHTSPierre  LegaultDirector BASKING RIDGEPierre  LegaultBASKING RIDGEDavid J  MazzoPresident and CEO BASKING RIDGEDavid J  MazzoChief Executive Officer BASKING RIDGEEllen  McDonaldSVP & Chief Business Officer BASKING RIDGEGwen A  MelincoffDirector SOUTH SAN FRANCISCOMichael  MendelsohnBASKING RIDGEMichael  MendelsohnDirector BASKING RIDGEMichael  MendelsohnDirector BASKING RIDGEMichael A  MetzgerPresident and COO BASKING RIDGEMichael A  MetzgerPresident & CEO BASKING RIDGEMendelsohn  MichaelBasking RidgeMetzger  MichaelBasking RidgeP SHERRILL  NEFFDirector BASKING RIDGEP SHERRILL  NEFFPHILADELPHIAP SHERRILL  NEFFDirector PHILADELPHIAA/S  Novo10% Owner BAGSVAERDNeff  P.Basking RidgeChristopher  PeetzChief Financial Officer SOUTH SAN FRANCISCONicholas J.  PelliccioneSr. VP of Regulatory Affairs BASKING RIDGEPentwater Capital Management LP10% Owner CHICAGOLegault  PierreBasking RidgeDennis  PodlesakDirector SAN DIEGODennis  PodlesakDirector BASKING RIDGEDennis  PodlesakDirector BASKING RIDGEDennis  PodlesakDirector BASKING RIDGEQUAKER BIO VENTURES LP10% Owner PHILADELPHIAQUAKER BIOVENTURES CAPITAL LPPHILADELPHIAWishiewski  RaphaelBasking RidgeWisniewski  RaphaelBasking RidgeInvestments S.a.r.l.  RMILUXEMBOURGInvestments S.a.r.l.  RMI10% Owner MOSCOWChristopher Paul  RusconiDURHAMChristopher Paul  RusconiChief Scientific Officer BASKING RIDGEChristopher Paul  RusconiChief Scientific Officer BASKING RIDGERusnanoMedInvest LLCMOSCOWRusnanoMedInvest LLCMOSCOWSapphire Acquisition Corp.PARSIPPANYKATHLEEN K  SCHOEMAKER10% Owner PRINCETONNimesh  ShahPRINCETONJESSE I  TREUDirector PRINCETONNICOLE  VITULLORICHMONDNICOLE  VITULLO10% Owner PRINCETONECKARD  WEBERDirector SOUTH SAN FRANCISCORaphael  WisniewskiDirector BASKING RIDGERaphael  WisniewskiDirector BASKING RIDGESteven  ZelenkofskeSVP & Chief Medical Officer BASKING RIDGESteven  ZelenkofskeSVP & Chief Medical Officer BASKING RIDGEPersons related to DP VII ASSOCIATES LP - CADENCE PHARMACEUTICALS INCNamePositionCityHAZEL M  AKERSVP, GC & Secretary SAN DIEGOBRIAN G  ATWOODDirector SAN DIEGOBRIAN G  ATWOODDirector SAN DIEGOSAM L  BARKERSAN DIEGOSAM L  BARKERDirector SAN DIEGOMichael A  BermanDirector SAN DIEGOMichael A  BermanDirector SAN DIEGOJAMES C  BLAIRDirector PRINCETONJAMES B  BREITMEYEREVP, CMO SAN DIEGOScott A.  ByrdSVP, Chief Commercial Officer SAN DIEGOWILLIAM S  CRAIGSVP SAN DIEGOLAUREEN  DEBUONODirector SAN DIEGOASSOCIATES  DOMAIN10% Owner PRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VI Associates, L.P.10% Owner PRINCETONMICHAEL L  EAGLEDirector SAN DIEGOFHM V, LLCSEATTLEFHM V, LPSEATTLEFHM VI, L.L.C.SEATTLEFHM VI, L.P.SEATTLEALAN D  FRAZIERDirector SAN DIEGOFrazier Healthcare V, LP10% Owner SEATTLEFrazier Healthcare VI, L.P.SEATTLECAM L  GARNERDirector SAN DIEGOBrian K  Halak10% Owner PRINCETONKim P.  Kamdar10% Owner PRINCETONWILLIAM R  LARUESVP, CFO, Treas, Asst Sec SAN DIEGOMalcolm  Lloyd-SmithSVP, Reg Affairs, Qual & Clin SAN DIEGORichard E  LowenthalVP SAN DIEGOJay  MoorinPRINCETONJay  MoorinPRINCETONROBERT J  MORE10% Owner PRINCETONROBERT J  MOREPRINCETONStephen L  NewmanDirector SAN DIEGOProQuest Associates III LLCPRINCETONProQuest Associates III LLCPRINCETONProQuest Investments III, L.P.10% Owner PRINCETONProQuest Investments III, L.P.10% Owner PRINCETONProQuest Management LLCPRINCETONProQuest Management LLCPRINCETONProQuest Management LLCPRINCETONTodd W  RichDirector SAN DIEGOMike A  RoyalVP SAN DIEGOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONALAIN  SCHREIBERPRINCETONALAIN  SCHREIBERPRINCETONALAIN  SCHREIBERSAN DIEGOTheodore R  SchroederPresident, CEO SAN DIEGODavid A  SocksSVP SAN DIEGOJESSE I  TREU10% Owner PRINCETONJESSE I  TREU10% Owner PRINCETONCHRISTOPHER J  TWOMEYDirector SAN DIEGONICOLE  VITULLO10% Owner PRINCETONPersons related to DP VII ASSOCIATES LP - ZOGENIX, INC.NamePositionCityZisson  AlexMinneapolisRhoads  AnnSan DiegoMinocherhomjee  ArdaChicagoMinocherhomjee, Ph.D.  ArdaSan DiegoJAMES C  BLAIRDirector PRINCETONLOUIS C  BOCKDirector FOSTER CITYLOUIS C  BOCKDirector FOSTER CITYLOUIS C  BOCKDirector FOSTER CITYJAMES B  BREITMEYERDirector SAN DIEGOJAMES B  BREITMEYERDirector SAN DIEGOMark J  BrooksFOSTER CITYGarner  CamSan DiegoGarner  CamSan DiegoChicago Growth Management II, LLCCHICAGOChicago Growth Management II, LLCCHICAGOChicago Growth Management II, LLCCHICAGOChicago Growth Management II, LPCHICAGOChicago Growth Management II, LPCHICAGOChicago Growth Partners II L PCHICAGOChicago Growth Partners II L P CHICAGOClarus Lifesciences I, L.P.10% Owner CAMBRIDGEClarus Lifesciences I, L.P.10% Owner CAMBRIDGEClarus Ventures I, LLCCAMBRIDGEClarus Ventures I, LLCCAMBRIDGEClarus Ventures I Management, L.P.CAMBRIDGEClarus Ventures I Management, L.P.CAMBRIDGERobinson  CynthiaSan DiegoThierry J.P.  DarcisEVP / General Manager, Europe SAN DIEGONassif  DavidSan DiegoASSOCIATES  DOMAINPRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONDomain Partners VI, L.P.PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VI Associates, L.P.10% Owner PRINCETONJOSEPH  EDELMANMast  ErleSan DiegoMast  ErleSan DiegoGail M  FarfelEVP/Chief Development Officer NEW HAVENSTEPHEN J  FARRPresident and CEO HAYWARDSTEPHEN J  FARRSAN DIEGOSTEPHEN J  FARRPresident and COO SAN DIEGOSTEPHEN J  FARRPresident and COO SAN DIEGONICHOLAS  GALAKATOSCAMBRIDGENICHOLAS  GALAKATOSCAMBRIDGEBradley S.  GalerEVP/Chief Medical Officer SAN DIEGOCAM L  GARNERDirector CARLSBADCAM L  GARNERDirector SAN DIEGOCAM L  GARNERDirector SAN DIEGOKen  HaasDirector MENLO PARKBrian K  Halak10% Owner PRINCETONROGER  HAWLEYDirector BRISBANEROGER  HAWLEYChief Executive Officer SAN DIEGOROGER  HAWLEYChief Executive Officer SAN DIEGODENNIS  HENNERCAMBRIDGEDENNIS  HENNERCAMBRIDGEHaldeman  J.D.San DiegoBLAIR  JAMESPRINCETONKim P.  KamdarPRINCETONHaas  KenSan DiegoHaas  KenMenlo ParkWheeler  KurtCambridgeROBERT  LIPTAKCAMBRIDGEROBERT  LIPTAKCAMBRIDGEBock  LouisFoster CityERLE T  MASTDirector BOULDERERLE T  MASTDirector SAN DIEGOERLE T  MASTSAN DIEGOERLE T  MASTDirector SAN DIEGOPete  McNerneyMINNEAPOLISARDA PHD  MINOCHERHOMJEEDirector CHICAGOARDA PHD  MINOCHERHOMJEECHICAGOKATE  MITCHELLFOSTER CITYRory  O'DriscollFOSTER CITYPERCEPTIVE ADVISORS LLCWASHINGTONPERCEPTIVE LIFE SCIENCES MASTER FUND LTDWASHINGTONANN D  RHOADSEVP, CFO, Treasurer & Sec. SAN JOSEANN D  RHOADSEVP, CFO, Treasurer & Sec. SAN DIEGOANN D  RHOADSEVP, CFO, Treasurer & Sec. SAN DIEGOCynthia Y  RobinsonChief Development Officer SAN DIEGOCynthia Y  RobinsonChief Development Officer SAN DIEGOHawley  RogerSan DiegoScale Venture Management II, LLCFOSTER CITYScale Venture Partners II, LP10% Owner FOSTER CITYKATHLEEN K  SCHOEMAKER10% Owner PRINCETONRichard Scott  ShivelyChief Commercial Officer SAN DIEGONicholas  SimonCAMBRIDGENicholas  SimonCAMBRIDGEMichael P  SmithEVP, CFO, Treasurer & Sec. VANCOUVERMICHAEL  STEINMETZCAMBRIDGEMICHAEL  STEINMETZCAMBRIDGEFarr  StephenSan DiegoRENEE P  TANNENBAUMDirector SAN DIEGOJAMES E  THOMASMINNEAPOLISThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II, LLCMINNEAPOLISThomas, McNerney & Partners, LLCMINNEAPOLISTHOMAS MCNERNEY & PARTNERS LP MINNEAPOLISTMP Associates II LPMINNEAPOLISTMP ASSOCIATES LPMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISTMP Nominee, LLCMINNEAPOLISJESSE I  TREU10% Owner PRINCETONNICOLE  VITULLO10% Owner PRINCETONKURT  WHEELERDirector CAMBRIDGEKURT  WHEELERDirector CAMBRIDGESharon L  WienbarFOSTER CITYMARK C  WIGGINSDirector SAN DIEGOMARK C  WIGGINSDirector SAN DIEGOMARK C  WIGGINSDirector SAN DIEGOPersons related to DP VII ASSOCIATES LP - Orexigen Therapeutics, Inc.NamePositionCityHEATHER S  ACEEVP, Global Human Resources SAN DIEGOMoshe  Arkin HERZELIAMoshe  ArkinHERZELIACAROL A  BAUMVP, Commercialization LA JOLLABAUPOST GROUP LLC/MABOSTONJAMES C  BLAIR10% Owner PRINCETONLOUIS C  BOCKDirector FOSTER CITYLOUIS C  BOCKDirector FOSTER CITYLOUIS C  BOCKDirector SAN DIEGOLOUIS C  BOCKDirector FOSTER CITYLOUIS C  BOCKDirector LA JOLLAMark D  BoothChief Commercial Officer LA JOLLADORON  BREEN TEL AVIVDovey  BrianLa JollaFRANKLIN P  BYMASTERVP of Neuroscience SAN DIEGOFRANKLIN P  BYMASTERVP, Neuroscience LA JOLLAThomas R  CannellEVP, COO, Pres Global Com Prod LA JOLLAGRAHAM K  COOPERCFO and Treasurer SAN DIEGOGRAHAM K  COOPERCFO and Treasurer LA JOLLAMICHAEL A  COWLEYChief Scientific Officer SAN DIEGOMICHAEL A  COWLEYChief Scientific Officer LA JOLLAEndicott  DavidLa JollaWENDY L  DIXONDirector PRINCETONASSOCIATES  DOMAINPRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONDOMAIN PARTNERS V LP10% Owner PRINCETONBRIAN H  DOVEYDirector BRIAN H  DOVEYDirector PRINCETONBRIAN H  DOVEYDirector LA JOLLADP V ASSOCIATES LP10% Owner PRINCETONEDUARDO  DUNAYEVICHChief Medical Officer SAN DIEGOEDUARDO  DUNAYEVICHChief Medical Officer LA JOLLAWeber  EckardLa JollaDavid J.  EndicottDirector IRVINEDavid J.  EndicottDirector LA JOLLA, CAPeter D  FlynnSVP,  Dev, Reg Affairs, Safety SAN DIEGOJoseph P  HaganChief Business Officer LA JOLLABrian K  Halak10% Owner PRINCETONAce  HeatherLa JollaPeter  HonigDirector LA JOLLADEBORA  JORNDirector BRIDGEWATERHagan  JosephLa JollaKim P.  KamdarPRINCETONJason A  KeyesSVP, Chief Financial Officer LA JOLLADENNIS D  KIMSr. VP, Corporate Development LA JOLLASETH A  KLARMANBOSTONPreston  KlassenEVP, Global Development LA JOLLAKLEINER PERKINS CAUFIELD & BYERS X A LP10% Owner MENLO PARKKLEINER PERKINS CAUFIELD & BYERS X B LP10% Owner MENLO PARKKPCB X ASSOCIATES LLC10% Owner MENLO PARKJOSEPH  LACOBDirector SAN DIEGOJOSEPH  LACOBDirector LA JOLLAJAMES C  LANCASTER JRVP of Commercial Operations SAN DIEGORONALD P  LANDBLOOMVP, Medical and Regulatory SAN DIEGORONALD P  LANDBLOOMVP, Medical and Regulatory LA JOLLAZoth  LotaLa JollaBock  LouisLa JollaThomas P.  LynchEVP. General Counsel & Sec. LA JOLLAM. ARKIN (1999) LTD.HERZLIAPATRICK J  MAHAFFYDirector BOULDERPATRICK J  MAHAFFYDirector LA JOLLAANTHONY A  MCKINNEYChief Operating Officer SAN DIEGOANTHONY A  MCKINNEYChief Business Officer LA JOLLANarachi  MichaelLa JollaStephen A.  MogliaVP, Chief Accounting Officer LA JOLLAISRAEL  MORTEL AVIVROBERT J  MORE10% Owner PRINCETONMICHAEL  NARACHICEO & President CAMBRIDGEMICHAEL  NARACHIPresident and CEO LA JOLLAMICHAEL  NARACHIPresident and CEO LA JOLLAMahaffy  PatrickLa JollaHonig  PeterLa JollaWALTER  PISKORSKISVP, Technical Operations LA JOLLAMICHAEL  POWELLDirector LA JOLLAMICHAEL  POWELLDirector SAN FRANCISCOMICHAEL  POWELLDirector MENLO PARKMICHAEL  POWELLDirector SAN DIEGOKlassen  PrestonLa JollaSAK CORPBOSTONMichael C  ScaifeLA JOLLAScale Venture Management II, LLCFOSTER CITYScale Venture Partners II, LP10% Owner FOSTER CITYKATHLEEN K  SCHOEMAKER10% Owner PRINCETONRON  SENATORTEL AVIVSOFINNOVA VENTURE PARTNERS VI L P10% Owner SAN FRANCISCOSPHERA FUNDS MANAGEMENT LTD.TEL AVIVCannell  ThomasLa JollaLynch  ThomasLa JollaGARY D  TOLLEFSONPresident and CEO SAN DIEGOGARY D  TOLLEFSONPresident and CEO LA JOLLAJESSE I  TREU10% Owner PRINCETONJESSE I  TREU10% Owner PRINCETONDANIEL K  TURNER IIIDirector LA JOLLADANIEL K  TURNER IIIDirector LA JOLLADANIEL K  TURNER IIIDirector SAN DIEGOHeather D  TurnerVice President SAN DIEGOHeather D  TurnerSVP, Gen. Counsel & Secretary LA JOLLANICOLE  VITULLO10% Owner PRINCETONDawn  ViveashSVP/Head of Regulatory Affairs LA JOLLAECKARD  WEBERDirector SOUTH SAN FRANCISCOECKARD  WEBERDirector SAN DIEGOECKARD  WEBERDirector LA JOLLADixon  WendyLa JollaLOTA S  ZOTHDirector GAITHERSBURGLota S.  ZothDirector LA JOLLAPersons related to DP VII ASSOCIATES LP - Evoke Pharma IncNamePositionCityJAMES C  BLAIR10% Owner PRINCETONTodd C  BradyDirector SAN DIEGOTodd C  BradyDirector SOLANA BEACHGarner  CamSan DiegoMARILYN R.  CARLSONChief Medical Officer SOLANA BEACHMatthew J  D'OnofrioExec VP, Chief Bus. Officer SAN DIEGOMatthew J  D'OnofrioExec VP, Chief Bus. Officer SOLANA BEACHGonyer  DavidSan DiegoASSOCIATES  DOMAINPRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONBRIAN H  DOVEYBRIAN H  DOVEY10% Owner PRINCETONCAM L  GARNERDirector CARLSBADCAM L  GARNERDirector SAN DIEGOCAM L  GARNERDirector SAN DIEGOCAM L  GARNERDirector SOLANA BEACHSCOTT L  GLENNDirector LA JOLLASCOTT L  GLENNDirector SAN DIEGOSCOTT L  GLENNDirector SOLANA BEACHDavid A  GonyerPresident and CEO SAN DIEGODavid A  GonyerPresident and CEO SOLANA BEACHBrian K  Halak10% Owner PRINCETONMalcolm R  HillDirector SAN DIEGOMalcolm R  HillDirector SOLANA BEACHKim P.  KamdarPRINCETONWidder  KennethSan DiegoPATRICK F  LATTERELLSAN FRANCISCOPATRICK F  LATTERELLSAN FRANCISCOLVP GP III, LLC10% Owner SAN FRANCISCOLVP III Associates, L.P.SAN FRANCISCOLVP III Partners LPSAN FRANCISCOLVP LIFE SCIENCE VENTURES III L.P.SAN FRANCISCOLVPMC, LLCSAN FRANCISCOHill  MalcolmSan DiegoD'Onofrio  MattSan DiegoANN D  RHOADSDirector SAN JOSEANN D  RHOADSDirector SAN DIEGOANN D  RHOADSDirector SOLANA BEACHKATHLEEN K  SCHOEMAKER10% Owner PRINCETONGlenn  ScottSan DiegoNimesh  ShahPRINCETONBrady  ToddSan DiegoJESSE I  TREU10% Owner PRINCETONNICOLE  VITULLORICHMONDNICOLE  VITULLO10% Owner PRINCETONKENNETH J  WIDDERDirector RANCHO SANTA FEKENNETH J  WIDDERDirector SAN DIEGOKENNETH J  WIDDERDirector SOLANA BEACHPersons related to DP VII ASSOCIATES LP - OBALON THERAPEUTICS INCNamePositionCityRasdal  AndrewSan DiegoRasdal  AndrewSan DiegoRasdal  AndrewCARLSBADJAMES C  BLAIRPRINCETONMark  BristerVP of Research and Development SAN DIEGOKeval  DesaiMENLO PARKRAYMOND V  DITTAMOREDirector GLENWOOD SPRINGSDOMAIN PARTERS VII L P10% Owner PRINCETONFisher  DougSan DiegoFisher  DougCARLSBADC.  Sampson  DouglasSan DiegoBRIAN H  DOVEYNeil  Drake CARLSBADDouglas  FisherDirector MENLO PARKPHILIP T  GIANOSBrian K  HalakPRINCETONW Stephen  HolmesMENLO PARKLESLEY H  HOWEDirector VISTANooshin  HussainyVP of Finance CARLSBAD, CA 92008InterWest Management Partners X, LLCMENLO PARKINTERWEST PARTNERS X LP10% Owner MENLO PARKSteven Ernest  JohnsonVP of Operations CARLSBADKim P.  KamdarDirector PRINCETONKamdar  KimSan DiegoKamdar  KimSan DiegoKamdar  KimCARLSBADGilbert H  KlimanMENLO PARKLisa  MetznerVP of Marketing CARLSBADDAVID  MOATAZEDI CARLSBADErin  MoriseyVP Strategic Partnerships CARLSBADKHALED  NASRSAN FRANCISCOMatthew  NorwoodVP of Sales CARLSBADARNOLD L  ORONSKYMENLO PARKWilliam J.  PlovanicChief Financial Officer CARLSBADAndrew P  RasdalPresident & CEO SAN DIEGOJONAH  SHACKNAIDirector SCOTTSDALEStevenson  SharonSan DiegoStevenson  SharonSan DiegoStevenson  SharonCARLSBADSharon  StevensonDirector LAGUNA BEACHJESSE I  TREUPRINCETONAmy  VandenBergVP of Reg. and Clin. Affairs CARLSBADNICOLE  VITULLORICHMONDDonald R  YoungVP of Quality Assurance CARLSBADPersons related to DP VII ASSOCIATES LP - Esperion Therapeutics, Inc.NamePositionCityAisling Capital II LP10% Owner NEW YORKAisling Capital II LP10% Owner NEW YORKAISLING CAPITAL PARTNERS LLCNEW YORKAISLING CAPITAL PARTNERS LLCNEW YORKAISLING CAPITAL PARTNERS, LPNEW YORKAISLING CAPITAL PARTNERS, LPNEW YORKde Bord  AlisonSan FranciscoKiley  AlisonSan FranciscoAlta Partners Management VIII, LLCSAN FRANCISCOAlta Partners Management VIII, LLCSAN FRANCISCOAlta Partners VIII, L.P.10% Owner SAN FRANCISCOAlta Partners VIII, L.P.10% Owner SAN FRANCISCOGotto, Jr.  AntonioAnn ArborJAMES C  BLAIR10% Owner PRINCETONScott  BraunsteinDirector ANN ARBORFARAH  CHAMPSISAN FRANCISCOFARAH  CHAMPSISAN FRANCISCOJanney  DanielPlymouthJanney  DanielAnn ArborASSOCIATES  DOMAINPRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONGoldstein  DovPlymouthGoldstein  DovAnn ArborGoldstein  DovNew YorkBRIAN H  DOVEYBRIAN H  DOVEY10% Owner PRINCETONSTEVE  ELMSCHESTERSTEVE  ELMSNEW YORKPATRICK G  ENRIGHTDirector BURLINGAMEPATRICK G  ENRIGHTDirector MENLO PARKPATRICK G  ENRIGHTDirector ANN ARBORPATRICK G  ENRIGHTDirector MENLO PARKOmenn  GilbertAnn ArborDOV A MD  GOLDSTEINDirector KING OF PRUSSIADOV A MD  GOLDSTEINDirector NEW YORKDOV A MD  GOLDSTEINDirector NEW YORKANTONIO M MD D PHIL  GOTTO JRDirector NEW YORKANTONIO M MD D PHIL  GOTTO JRPLYMOUTHANTONIO M MD D PHIL  GOTTO JRDirector ANN ARBORBrian K  Halak10% Owner PRINCETONTroy A.  IgnelziPLYMOUTHDANIEL  JANNEYDirector SAN FRANCISCODANIEL  JANNEYDirector SAN FRANCISCODANIEL  JANNEYDirector SAN FRANCISCODANIEL  JANNEYDirector ANN ARBORKim P.  KamdarPRINCETONNarendra D.  LalwaniChief Operating Officer ANN ARBORLOUIS G  LANGEDirector PLYMOUTHLongitude Capital Associates, L.P.MENLO PARKLongitude Capital Associates, L.P.MENLO PARKLongitude Capital Partners, LLC10% Owner MENLO PARKLongitude Capital Partners, LLC10% Owner MENLO PARKLongitude Venture Partners L.P.MENLO PARKLongitude Venture Partners L.P.MENLO PARKLongitude Venture Partners L.P.MENLO PARKLange  LouisPlymouthLange  LouisPalo AltoMcGovern  MarkAnn ArborTIMOTHY M  MAYLEBENPresident & CEO ANN ARBORTIMOTHY M  MAYLEBENPresident & CEO ANN ARBORTIMOTHY M  MAYLEBENPresident and CEO PLYMOUTHTIMOTHY M  MAYLEBENPres & Chief Executive Officer PLYMOUTHMARK E  MCGOVERNDirector MARK E  MCGOVERNDirector PLYMOUTHMARK E  MCGOVERNDirector ANN ARBORMary  McGowanChief Medical Officer ANN ARBORROGER S  NEWTONDirector ANN ARBORROGER S  NEWTONExecutive Chairman, CSO PLYMOUTHROGER S  NEWTONExecutive Chairman & C.S.O. PLYMOUTHROGER S  NEWTONExecutive Chairman & CSO ANN ARBORVitullo  NicolePlymouthVitullo  NicoleAnn ArborVitullo  NicolePrinctonVitullo  NicolePrincetonRosenberg  NoahPlymouthGUY P  NOHRASAN FRANCISCOGUY P  NOHRASAN FRANCISCOGILBERT S  OMENNDirector THOUSAND OAKSGILBERT S  OMENNDirector ANN ARBOREnright  PatrickAnn ArborEnright  PatrickPlymouthDennis J  PurcellNEW YORKDennis J  PurcellNEW YORKNewton  RogerPlymouthNewton  RogerPlymouthNewton  RogerAnn ArborNoah L.  RosenbergChief Medical Officer PLYMOUTHANDREW N  SCHIFFNEW YORKDR DREW  SCHIFFNEW YORKKATHLEEN K  SCHOEMAKER10% Owner PRINCETONNimesh  ShahPRINCETONBakker Juliet  TammenomsMENLO PARKBakker Juliet  TammenomsMENLO PARKMayleben  TimPlymouthMayleben  TimAnn ArborMayleben  TimothyAnn ArborJESSE I  TREU10% Owner PRINCETONIgnelzi  TroyPlymouthNICOLE  VITULLODirector RICHMONDNICOLE  VITULLODirector PRINCETONPersons related to DP VII ASSOCIATES LP - TANDEM DIABETES CARE INCNamePositionCityDick  AllenDirector SAN DIEGORobert  AnaconeEVP & CHIEF COMMERICAL OFFICER SAN DIEGORobert  AnaconeEVP & CHIEF COMMERICAL OFFICER SAN DIEGORobert  AnaconeSAN DIEGOHENRY  ANHALTDirector SAN DIEGODAVID B  BERGEREVP, GEN. COUNSEL & SECRETARY SAN DIEGODAVID B  BERGERGENERAL COUNSEL SAN DIEGOJAMES C  BLAIR10% Owner PRINCETONKIM D  BLICKENSTAFFPRESIDENT & CEO KIM D  BLICKENSTAFFPRESIDENT AND CEO SAN DIEGOKIM D  BLICKENSTAFFSAN DIEGOJAMES J  BOCHNOWSKIMENLO PARKDAVID  BONDERMANFORT WORTHEDWARD L  CAHILLDirector BOSTONEDWARD L  CAHILLDirector BOSTONJohn  CajigasEVP, CFO & TREASURER SAN DIEGOFred E  CohenDirector SAN FRANCISCOFred E  CohenDirector FORT WORTHFred E  CohenFORT WORTHFred E  CohenDirector FORT WORTHJAMES G  COULTERFORT WORTHDelphi BioInvestments VIII LPMENLO PARKDelphi Management Partners VIII, L.L.C.10% Owner MENLO PARKDELPHI VENTURES VIII LPMENLO PARKAllen  DickSan DiegoAllen  DickSan DiegoDOMAIN PARTERS VII L P10% Owner PRINCETONRoeder  DouglasMenlo ParkDAVID L  DOUGLASSMENLO PARKDAVID L  DOUGLASSMENLO PARKBRIAN H  DOVEY10% Owner PRINCETONCahill  EdwardBostonCahill  EdwardBostonHOWARD E  GREENE JRDirector HOWARD E  GREENE JRDirector SAN DIEGOPETER J  GRUABOSTONBrian K  Halak10% Owner PRINCETONBRIAN B  HANSENEVP & CHIEF COMMERCIAL OFFICER SAN DIEGOHLM Venture Associates II, LLCBOSTONHLM VENTURE PARTNERS II, L.P.10% Owner BOSTONGreene  HowardSan DiegoGreene  HowardSan DiegoTreu  JesseSan DiegoTreu  JesseSan DiegoCajigas  JohnSan DiegoCajigas  JohnSan DiegoLivingston  JohnSan DiegoLivingston  JohnSan DiegoGrossman  KeithSan FranciscoBlickenstaff  KimSan DiegoBlickenstaff  KimSan DiegoSusan  MorrisonCHIEF ADMINSTRATIVE OFFICER SAN DIEGOBrown  NedSan DiegoDEEPIKA  PAKIANATHANMENLO PARKDiPerna  PaulSan DiegoSekhri  PaulSan FranciscoRUSSELL T  RAYBOSTONDOUGLAS A  ROEDERDirector MENLO PARKDOUGLAS A  ROEDERMENLO PARKDOUGLAS A  ROEDERDirector MENLO PARKKATHLEEN K  SCHOEMAKER10% Owner PRINCETONJohn F  SheridanEVP, CHIEF OPERATING OFFICER RANCHO CORDOVAJohn F  SheridanEVP & CHIEF OPERATING OFFICER SAN DIEGOLONNIE M  SMITHDirector SAN DIEGOLONNIE M  SMITHDirector SAN DIEGOTPG Group Holdings (SBS) Advisors, Inc.10% Owner FORT WORTHJESSE I  TREUDirector PRINCETONCHRISTOPHER J  TWOMEYDirector CHRISTOPHER J  TWOMEYDirector SAN DIEGONICOLE  VITULLO10% Owner PRINCETONPersons related to DP VII ASSOCIATES LP - Clovis Oncology, Inc.NamePositionCityAndrew R  AllenSee Remarks BOULDERAndrew R  AllenSee Remarks BOULDERAllen  AndrewBoulderAllen  AndrewBoulderAllen  AndrewBoulderBRIAN G  ATWOODDirector MENLO PARKBRIAN G  ATWOODMENLO PARKBRIAN G  ATWOODDirector MENLO PARKM JAMES  BARRETTDirector BALTIMOREM JAMES  BARRETTDirector TIMONIUMPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner TIMONIUMJAMES C  BLAIRDirector PRINCETONAtwood  BrianBoulderASSOCIATES  DOMAINPRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONRYAN D  DRANT10% Owner TIMONIUMMcKinley  EdwardBoulderMast  ErleBoulderMast  ErleBoulderKeith T.  FlahertyDirector BOULDERIvers-Read  GillianBoulderIvers-Read  GillianBoulderGraham  GingerBoulderGINGER L  GRAHAMDirector GINGER L  GRAHAMDirector BOULDERBrian K  Halak10% Owner PRINCETONSteven L.  HoerterSee Remarks BOULDERCorwin Dale  HooksSee Remarks BOULDERGILLIAN C  IVERS-READSee Remarks BOULDERGILLIAN C  IVERS-READSee Remarks BOULDERBlair  JamesBoulderKim P.  KamdarPRINCETONFlaherty  KeithBoulderPATRICK J  KERINS10% Owner TIMONIUMPAUL H  KLINGENSTEINDirector PALO ALTOPAUL H  KLINGENSTEINDirector SAN FRANCISCOKRISHNA KITTU  KOLLURI10% Owner TIMONIUMC RICHARD  KRAMLICH10% Owner TIMONIUMBarret  M.BoulderPATRICK J  MAHAFFYSee Remarks BOULDERPATRICK J  MAHAFFYSee Remarks BOULDERERLE T  MASTExecutive VP and CFO BOULDERERLE T  MASTExecutive VP and CFO BOULDER,ERLE T  MASTExecutive VP and CFO BOULDEREdward J  McKinleyDirector LONDON SW10 9NF UNITED KINGDOMEdward J  McKinleyDirector BOULDERDAVID M  MOTT10% Owner TIMONIUMDANIEL W  MUEHLSee Remarks NORTH BILLERCANEA 13 GP, LtdTIMONIUMPartners 13, Limited Partnership  NEA10% Owner TIMONIUMNEW ENTERPRISE ASSOCIATES 13 LP10% Owner TIMONIUMMahaffy  PatrickBoulderMahaffy  PatrickBoulderMahaffy  PatrickBoulderKlingenstein  PaulBoulderJOHN C  REEDDirector BOULDERLindsey  RolfeSee Remarks BOULDERSCOTT D  SANDELL10% Owner TIMONIUMKATHLEEN K  SCHOEMAKER10% Owner PRINCETONTHORLEF  SPICKSCHENDirector GERMANYTHORLEF  SPICKSCHENDirector BOULDERHoerter  StevenBoulderSpickschen  ThorlefBoulderJESSE I  TREU10% Owner PRINCETONVersant Side Fund IV, L.P.MENLO PARKVersant Side Fund IV, L.P.MENLO PARKVersant Side Fund IV, L.P.MENLO PARKVersant Venture Capital IV, L.P.MENLO PARKVersant Venture Capital IV, L.P.10% Owner MENLO PARKVersant Venture Capital IV, L.P.10% Owner MENLO PARKVersant Ventures IV, LLCMENLO PARKVersant Ventures IV, LLCMENLO PARKVersant Ventures IV, LLCMENLO PARKRavi  Viswanathan10% Owner TIMONIUMNICOLE  VITULLO10% Owner PRINCETONHarry R  Weller10% Owner TIMONIUMPersons related to DP VII ASSOCIATES LP - Neothetics, Inc.NamePositionCityAlta Partners Management VIII, LLCSAN FRANCISCOAlta Partners VIII, L.P.10% Owner SAN FRANCISCOJAMES C  BLAIRPRINCETONFARAH  CHAMPSISAN FRANCISCOFARAH  CHAMPSISAN FRANCISCOMARTHA J  DEMSKIDirector SAN DIEGO,MARTHA J  DEMSKISAN DIEGOASSOCIATES  DOMAINPRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONBRIAN H  DOVEYPRINCETONMaria  FeldmanVP, Clinical Research SAN DIEGOMaxim  GorbachevDirector SAN DIEGOBrian K  HalakPRINCETONDANIEL  JANNEYDirector SAN FRANCISCODANIEL  JANNEYDirector SAN FRANCISCOKim P.  KamdarDirector PRINCETONChristopher  KemmererVP, Pharma Dev & Manufacturing SAN DIEGOSusan A.  KnudsonChief Financial Officer SAN DIEGOLINCOLN  KROCHMALChief Medical Officer SAN DIEGOKenneth W  LockeChief Scientific Officer SAN DIEGO,Kenneth W  LockeChief Scientific Officer SAN DIEGOGeorge W  MahaffeyPresident and CEO SOUTH SAN FRANCISCOGeorge W  MahaffeySAN DIEGOGUY P  NOHRASAN FRANCISCOGUY P  NOHRASAN FRANCISCOJeffrey M  NugentDirector SAN MATEOInvestments S.a.r.l.  RMI10% Owner GRAND DUCHYRusnanoMedInvest LLCMOSCOWRusnanoMedInvest LLCMOSCOWKATHLEEN K  SCHOEMAKERPRINCETONNimesh  ShahPRINCETONJESSE I  TREUPRINCETONNICOLE  VITULLOPRINCETONPatricia S  WalkerSAN DIEGOHANI M  ZEINIDirector SANTA BARBARA












 






﻿







Dp Vii Associates Lp Who Is Evoke Pharma Inc (NASDAQ:EVOK) Insider, Unloaded 202 Shares of the Company – Octafinance
























































 








Friday, 28 July 2017

























 

Menu



Featured News


						2 years ago - Alphabet Inc (NASDAQ:GOOGL) Tests Its Ad Technology On Billboards To Cushion Itself Against Ad Blocks


						2 years ago - China Margin Debt Hits 8-Week High, Japan Pumps’n’Dumps As Kyle Bass Fears Looming EM Banking Crisis


						2 years ago - Marc Faber Shares His Insight in One Hour Exclusive Interview. He Covers All From Commodities and China to Inflation, The Euro and Gold


						2 years ago - Carl Icahn Criticizes the Fed. Feels Bad For Investors Buying Junk Bonds


						2 years ago - John Burbank: European QE Can’t Save The Markets Same As the U.S. Quantitative Easing. Everything Will Be Liquidated










Dp Vii Associates Lp Who Is Evoke Pharma Inc (NASDAQ:EVOK) Insider, Unloaded 202 Shares of the Company


08/20/2015  by OctaStaff 
			in Insider News 












Share with your friendsYour NameYour EmailRecipient EmailEnter a MessageI read this article and found it very interesting, thought it might be interesting for you. The article is called Dp Vii Associates Lp Who Is Evoke Pharma Inc (NASDAQ:EVOK) Insider, Unloaded 202 Shares of the Company and is was published by Octafinance.com at http://www.octafinance.com/dp-vii-associates-lp-who-is-evoke-pharma-inc-nasdaqevok-insider-unloaded-202-shares-of-the-company/169322/.CaptchaSubmit
Dp Vii Associates Lp Insider Buy Transaction
 The insider of Evoke Pharma Inc (NASDAQ:EVOK)  2.32 -0.09 -3.73%, Dp Vii Associates Lp sold 202 shares of the firm based on the average share price which is $7.0 for share. The transaction’s shares have a market value of about $1,418 U.S. Dollars. Dp Vii Associates Lp now owns 10%+ of the total market capitalization of Evoke Pharma Inc. The insider trading deal took place on August 20, 2015 and was revealed in the a report at the (SEC)’s website.
Evoke Pharma Inc Stock Rating, Sentiment and Fundamentals
 According to five expert stock analysts that are covering Evoke Pharma Inc’s earnings potential, there is an expectation of earnings for each share of $-2.15 for the 2015 year, which gives Evoke Pharma Inc a price to earnings ratio of NaN. Evoke Pharma Inc is expected to have earnings-per-share growth rate of 40.00% Year-Over-Year.






Rating & SentimentPsychSignal Social:SELLAnalysts Rating:BUYHedge Funds Sentiment:-




Stock FundamentalsEarnings + FCF Trend:BUYSector/Industry Macro:BULLISHValuation Models:-


 


Technical AnalysisST Trend:DOWNMT Trend:DOWNLT Trend:DOWN




OctaFinance Rating*:SELL


* Read How Our Stock Ratings System Works








 Evoke Pharma Inc is also in a weak down trend. Over the last 200 days the stock price has lost roughly 37.91%. Our time momentum model, coupled with Dp Vii Associates Lp’s transaction, certainly serves to classify this stock as a SELL. 
Price Chart of Evoke Pharma NASDAQ:EVOK Stock
 
Source: RightEdgeSystems, Yahoo Split & Dividend Adjusted Data and OctaFinance Interpretations
 As famous stock traders including Ray Dalio stated, best money is made through a mix of fundamental & technical analysis.
Hedge Funds Ownership
 SEC 13F filings showed that, 10 institutional investors own shares of Evoke Pharma Inc. In Q4 2014, the firm had 6.37% institutional ownership. That is a low interest. Its down 0.24% from previous quarter. These owners decreased the total shares they own by 955 to 403,851 this quarter. There were 2 funds that closed their positions and 2 that reduced them. A total of 3 funds opened new positions in Evoke Pharma Inc and 2 increased their holdings.

 James A. Silverman’s Opaleye Management Inc. had the greatest investment with ownership of 240,000 shares as of Q4 2014 for 0.72% of the fund’s portfolio. Cam Group Holding A S is another positive institutional manager possessing 45,100 shares of the company or less than 0.01% of their stocks portfolio. California Public Employees Retirement System have less than 0.01% of their stock portfolio invested in the stock for 36,700 shares. Moreover, Tower Research Capital Llc (Trc) revealed it had purchased a stake worth less than 0.01% of the fund’s stock portfolio in the company. The Massachusetts-based fund Geode Capital Management Llc was also a big supporter of the stock, with ownership of 15,864 shares. Evoke Pharma Inc is less than 0.01% of the fund’s stock portfolio.
Evoke Pharma NASDAQ:EVOK Company Profile
Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The Company’s lead product candidate, EVK-001, is in late stage clinical testing. EVK-001 is a formulation of this drug, designed to provide systemic delivery of metoclopramide through intranasal administration. Gastroparesis is a condition of delayed gastric emptying in the absence of mechanical obstruction. Gastroparesis results in food remaining in the stomach for a longer time than normal, yielding a variety of symptoms.
Company Website: Evoke Pharma
 The company has 7 employees. At the moment its market worth is: $26.64 million and it has 6.40 million shares outstanding. Today there are 8.04% shareholders and the institutional ownership is 8.04%. Evoke Pharma Inc was founded in Delaware on 2007-01-29. The stock closed at $4.16 yesterday and it had average 2 days volume of 61480 shares. It is up from the 30 days average shares volume of 19025. Evoke Pharma Inc has a 52weeks low of $4.01 and a one year high of $8.32. The current price is below the 200 days Simple moving average. Evoke Pharma Inc last issued its quarterly earnings stats on 08/13/2015. The company reported -0.52 EPS for the quarter, above the consensus estimate of -0.61 by 0.09. The company had a revenue of for 3/31/2015 and for 12/31/2014. Therefore, the revenue was down.
Dp Vii Associates Lp is also 10 percent owner of Tobira Therapeutics, Inc., Neothetics, Inc., Cadence Pharmaceuticals Inc, Achaogen Inc, Tandem Diabetes Care Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., Orexigen Therapeutics, Inc., Zogenix, Inc.
* The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below – each of whom is a managing member of One Palmer Square Associates VII – LLC (“OPSA VII”) – the sole general partner of the Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4 – each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the Reporting Person – however each of them disclaims beneficial ownership of any securities – and any proceeds thereof – that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
* As managing members of OPSA VII – which is also the sole general partner of Domain Partners VII – L.P. each Reporting Owner listed below may also be deemed to indirectly beneficially own 1 – 052 – 328 shares of Common Stock held by Domain Partners VII – L.P. Pursuant to Instruction 4(b)(iv) of Form 4 – each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by Domain Partners VII – L.P. – however each of them disclaims beneficial ownership of any securities – and any proceeds thereof – that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
* As managing members of Domain Associates – LLC – each Reporting Owner listed below may also be deemed to indirectly beneficially own 5 – 250 shares of Common Stock held by Domain Associates – LLC. Pursuant to Instruction 4(b)(iv) of Form 4 – each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by Domain Associates – LLC – however each of them disclaims beneficial ownership of any securities – and any proceeds thereof – that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.







 
Tagged: Dp Vii Associates LpEvoke Pharma - (NASDAQ:EVOK)



Madison Dearborn Partners Llc, CDW Corp (NASDAQ:CDW)’s insider Sold 6,550,571 Shares Glenn W. Wellings ENGAGED CAPITAL Just Filed 13F Holdings for Q2 2015 



 





Free Email Newsletter
    Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:







Hedge Fund NewsTop 10 CITADEL ADVISORS 13F Holdings in Q3 2015DF DENT & CO INC Just Released Its Q3 2015 Stock PositionsMAVERICK CAPITAL Top 10 Holdings in Q3 2015Analyzing Ken Griffins CITADEL ADVISORS Stock Holdings in Q3 2015LONE PINE CAPITAL Top 10 13F Positions in Q3 2015Guru NewsFelix Zulauf Sees a Stock Market Correction Coming. This Rally S&P 500 (INDEXSP:.INX) Will Be Short-LivedMarc Faber Shares His Insight in One Hour Exclusive Interview. He Covers All From Commodities and China to Inflation, The Euro and GoldJim Grant: The Next Thing Might Be Helicopter Money. What to Buy and Where He Sees Investment OpportunitiesKyle Bass Bearish on Emerging Markets for at least 2 More Years. Looking to Short CurrenciesDavid Tepper Gets Defensive. Is it Time to Get Out of The Stock Market?


Macro NewsChina Margin Debt Hits 8-Week High, Japan Pumps’n’Dumps As Kyle Bass Fears Looming EM Banking CrisisAre US – Russian Relations A Zero-Sum Game?US and Russia have launched direct talks on the conflict in SyriaYuan Drops as PBOC Cuts Reference Rate by Most Since DevaluationCould the market crash like 1987?—put volume spike argues low is nearCTAs NewsRed Rock Just Published Report About The Trend Following Landscape & How CTAs’ Performance Must Be AnalyzedHow to Implement Dual Momentum for non-US InvestorsDo Commodity Trading Advisors (CTAs) Really Provide Crisis Alpha, Equity Hedge and Are Long Volatility?





















DP VI Associates, L.P. - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











DP VI Associates, L.P.
Check out list of companies and businesses related to DP VI Associates, L.P.. Find out DP VI Associates, L.P. address and contact details. View other people related to DP VI Associates, L.P. - coworkers, colleagues, companions, etc.
Address:   

C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE PRINCETON 08542 NJ




Companies related to DP VI Associates, L.P.
CIKCompany NamePositionCompany Address0001267602ALIMERA SCIENCES INC10% Owner 6120 WINDWARD PARKWAY STE 290 ALPHARETTA 300050001267813MARINUS PHARMACEUTICALS INC10% Owner 170 N RADNOR CHESTER RD SUITE 250 RADNOR 190870001274644Ocera Therapeutics, Inc.555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY 940650001311596Tobira Therapeutics, Inc.10% Owner 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO 940800001327467Celator Pharmaceuticals Inc303B COLLEGE ROAD EAST  PRINCETON 085400001333248CADENCE PHARMACEUTICALS INC10% Owner 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO 921300001339455Pernix Sleep, Inc.10% Owner 440 STEVENS AVENUE, SUITE 200 SOLANA BEACH 920750001341235Aldeyra Therapeutics, Inc.10% Owner 131 HARTWELL AVENUE SUITE 320 LEXINGTON 024210001347178Vanda Pharmaceuticals Inc.10% Owner 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON 200370001348649CoLucid Pharmaceuticals, Inc.10% Owner 222 THIRD STREET  CAMBRIDGE 021420001375151ZOGENIX, INC.10% Owner 5858 HORTON STREET, #455  EMERYVILLE 946080001395937Syndax Pharmaceuticals IncDirector 400 TOTTEN POND ROAD SUITE 110 WALTHAM 02451




DP VI Associates, L.P. on the Web
Persons related to DP VI Associates, L.P. - ALIMERA SCIENCES INCNamePositionCitySRINIVAS  AKKARAJUMENLO PARKHove  AndersPalo AltoPhilip  AshmanSVP, EU Managing Director ALPHARETTABA Venture Partners VI, LLCFOSTER CITYBAVP, L.P.10% Owner FOSTER CITYBAVP, L.P.10% Owner FOSTER CITYJAMES C  BLAIR10% Owner PRINCETONLOUIS C  BOCKFOSTER CITYGLEN  BRADLEYDirector HENDERSONGLEN  BRADLEYALPHARETTAGLEN  BRADLEYDirector ALPHARETTAHalak  BrianAlpharettaHalak  BrianPrincetonMark J  BrooksDirector NORTH HOLLYWOODMark J  BrooksDirector FOSTER CITYYoungren  BryceWalthamYoungren  BryceAlpharettaMyers  C.AlpharettaSusan  CaballaSEE REMARKS ALPHARETTASusan  CaballaSee Remarks ALPHARETTARoberts  CalvinAlpharettaMyers  CharlesAlpharettaHolland  DavidAlpharettaDEERFIELD CAPITAL LP ET ALNEW YORKMANAGEMENT CO /NY  DEERFIELDDeerfield Mgmt III, L.P.NEW YORKDeerfield Private Design Fund II, L.P.NEW YORKDeerfield Private Design Fund III, L.P.NEW YORKDeerfield Private Design International II, L.P.ROAD TOWN, TORTOLADeerfield Special Situations Fund, L.P.NEW YORKDomain Partners VI, L.P.10% Owner PRINCETONDomain Partners VI, L.P.PRINCETONDennis  DoughertyDURHAMBRIAN H  DOVEY10% Owner PRINCETONRICHARD S  EISWIRTH JRPresident and CFO ALPHARETTARICHARD S  EISWIRTH JRCOO & CFO ALPHARETTAJonathan A  FlintWALTHAMJames E  Flynn10% Owner NEW YORKKong  GarhengAlpharettaBradley  GlenAlpharettaKenneth  GreenSVP & Chief Scientific Officer ALPHARETTAKenneth  GreenSee Remarks ALPHARETTABrian K  HalakDirector PRINCETONJAMES  HEALYMENLO PARKJAMES  HEALYMENLO PARKDavid  HollandSVP of Sales and Marketing ALPHARETTADavid  HollandSVP of Sales and Marketing ALPHARETTAAnders D  HoveDirector NEW YORKINTERSOUTH AFFILIATES V LPDURHAMIntersouth Associates V, LLC10% Owner DURHAMIntersouth Associates VI, LLC10% Owner DURHAMIntersouth Associates VII, LLC10% Owner DURHAMIntersouth Partners V, L.P.DURHAMINTERSOUTH PARTNERS VI LPDURHAMINTERSOUTH PARTNERS VII L PDURHAMLargent  JamesAlpharettaGreen  KennethAlpharettaGarheng  KongDirector CHAPEL HILLGarheng  KongDirector MENLO PARKGarheng  KongDirector MENLO PARKJames R  LargentDirector SANTA ANAJames R  LargentDirector ALPHARETTAPatrick  Lee10% Owner PALO ALTOBrooks  MarkFoster CityBrooks  MarkAlpharettaTERRANCE  MCGUIREWALTHAMAnand  MehraMENLO PARKKATE  MITCHELLFOSTER CITYKATE  MITCHELLFOSTER CITYMitch  MummaDURHAMC. Daniel  MyersCEO ALPHARETTAC. Daniel  MyersPresident and CEO ALPHARETTARory  O'DriscollFOSTER CITYRory  O'DriscollFOSTER CITYPALO ALTO HEALTHCARE FUND II L PPALO ALTOPALO ALTO HEALTHCARE FUND, L.P.PALO ALTOPALO ALTO HEALTHCARE MASTER FUND, L.P.PALO ALTOALTO INVESTORS  PALOPALO ALTOPalo Alto Investors, LLCPALO ALTOPizzo  PeterAlpharettaTracy  PhilAlpharettaTracy  PhilipDurhamTracy  PhilipAlpharettaPeter J.  Pizzo IIIDirector ALPHARETTAPeter J.  Pizzo IIIDirector ALPHARETTAPolaris Venture Management Co IV LLC10% Owner WALTHAMPOLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LPWALTHAMPOLARIS VENTURE PARTNERS IV LPWALTHAMMICHAEL  POWELLMENLO PARKMICHAEL  POWELLMENLO PARKEiswirth  RichardAlpharettaCalvin W.  RobertsDirector ALPHARETTACalvin W.  RobertsDirector ALPHARETTAScale Venture Management I, LLCFOSTER CITYKATHLEEN K  SCHOEMAKER10% Owner PRINCETONSofinnova Management VIII, L.L.C.MENLO PARKSofinnova Management VIII, L.L.C.10% Owner MENLO PARKSofinnova Venture Partners VIII, L.P.MENLO PARKSofinnova Venture Partners VIII, L.P.MENLO PARKALAN G  SPOONWALTHAMCaballa  SusanAlpharettaPHILIP R  TRACYDURHAMPHILIP R  TRACYDirector DURHAMPHILIP R  TRACYDirector DURHAMJESSE I  TREU10% Owner PRINCETONVEF Management IV, LLCPALO ALTOVENROCK ASSOCIATES IV L P10% Owner PALO ALTOVENROCK ENTREPRENEURS FUND IV L PPALO ALTOVenrock Management IV, LLCPALO ALTOVenrock Partners, L.P.PALO ALTOVenrock Partners Management, LLCPALO ALTONICOLE  VITULLO10% Owner PRINCETONBryce  YoungrenDirector WALTHAMPersons related to DP VI Associates, L.P. - MARINUS PHARMACEUTICALS INCNamePositionCityBARBER  ALANBRANFORDMEHRA  ANANDBRANFORDMehra, M.D.  AnandBranfordMehra, M.D.  AnandNew HavenGopka  AntonBranfordGopka  AntonNew HavenAlain  AzanSAN FRANCISCOAlain  AzanMENLO PARKJAMES C  BLAIRPRINCETONStephen M  BlochDirector WESTPORTStephen M  BlochNEW HAVENStephen M  BlochDirector WESTPORTEric  BuatoisSAN FRANCISCOEric  BuatoisMENLO PARKSTUART  CABLEBOSTONCanaan Partners VII LLCWESTFORDCanaan Partners VII LLCWESTPORTCanaan VII L P10% Owner WESTFORDCanaan VII L PDirector WESTPORTCanaan VII LPDirector WESTPORTEnrique J.  CarrazanaDirector HAWTHORNEEnrique J.  CarrazanaDirector NEW HAVENChristopher Michael  CashmanChairman and CEO NEW HAVENChristopher Michael  CashmanPRESIDENT AND CEO NEW HAVENChristopher Michael  CashmanPresident and CEO RADNORCashman  ChristopherBranfordCashman  ChristopherNew HavenASSOCIATES  DOMAINPRINCETONDomain Partners VI, L.P.10% Owner PRINCETONMICHAEL R  DOUGHERTYBRIAN H  DOVEYPRINCETONGail M  FarfelChief Clinical Dev & Reg Offic NEW HAVENGail M  FarfelChief Clinical Dev & Reg RADNORSeth H.Z.  FischerDirector SAN DIEGOAnton  GopkaDirector NEW HAVENBrian K  HalakPRINCETONPENNER, JR.  HARRYBRANFORDPenner  HarryBranfordPenner  HarryNew HavenRein  HarryBranfordRein  HarryNew HavenJAMES  HEALYBRISBANEJAMES  HEALYMENLO PARKKRAYACICH  JOHNBRANFORDKim P.  KamdarPRINCETONSHAW  KENNETHBRANFORDMasuoka K.  LorianneSAN CARLOSTIMOTHY M  MAYLEBENDirector ANN ARBORTIMOTHY M  MAYLEBENDirector NEW HAVENAnand  Mehra10% Owner MENLO PARKAnand  MehraDirector MENLO PARKVitullo  NicoleNew HavenVITULLO  NICOLEBRANFORDAlbena  PatronevaChief Medical Officer RADNORMICHAEL  POWELLMICHAEL  POWELLMENLO PARKKATHLEEN K  SCHOEMAKERPRINCETONNimesh  ShahPRINCETONJay  ShepardDirector CUPERTINOJay  ShepardDirector NEW HAVENEdward F  SmithCFO PHILADELPHIAEdward F  SmithNEW HAVENEdward F  SmithCFO RADNORSofinnova Management VI, L.L.C.SAN FRANCISCOSofinnova Management VI, L.L.C.MENLO PARKSofinnova Venture Affiliates VI LPMENLO PARKSofinnova Venture Affiliates VI LPMENLO PARKSofinnova Venture Partners VI GmbH & Co. KGMENLO PARKSofinnova Venture Partners VI GmbH & Co. KGMENLO PARKSOFINNOVA VENTURE PARTNERS VI L PSAN FRANCISCOSOFINNOVA VENTURE PARTNERS VI L PMENLO PARKBLOCH  STEPHENBRANFORDBloch, M.D.  StephenBranfordBloch, M.D.  StephenNew HavenMayleben  TimothyNew HavenMAYLEBEN  TIMOTHYBRANFORDJESSE I  TREUPRINCETONNICOLE  VITULLODirector RICHMONDNICOLE  VITULLODirector PRINCETONPersons related to DP VI Associates, L.P. - Ocera Therapeutics, Inc.NamePositionCity14159 capital (GP), LLC10% Owner NEW YORKDavidson  AaronDurhamGEORGE B  ABERCROMBIEDirector DURHAMGEORGE B  ABERCROMBIEDirector DURHAMGaurav  AggarwalChief Business Officer SOUTH SAN FRANCISCOGaurav  AggarwalChief Business Officer PALO ALTOERIC  AGUIARSTAMFORDERIC  AGUIARMINNEAPOLISZisson  AlexDurhamVanLent  AnneSan DiegoVanLent  AnnePalo AltoAlain  AzanMENLO PARKBaker Biotech Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences Capital (GP), LLC10% Owner NEW YORKFELIX  BAKERNEW YORKJULIAN  BAKERNEW YORKBDC CAPITAL INC.10% Owner MONTREAL, QUEBEC, CANADAJAMES C  BLAIR10% Owner PRINCETONGavin  BrendaDurhamEric  BuatoisMENLO PARKStan  BukofzerChief Medical Officer PALO ALTOMichael  ByrnesCFO and Treasurer PALO ALTOregional et cooperatif Desjardins  Capital10% Owner MONTREAL, QUEBEC, CANADAJean-Paul  CastaigneDirector DURHAMJean-Paul  CastaigneDirector DURHAMJean-Paul  CastaigneDirector PALO ALTOMcGowan  DanaSan DiegoDrutz  DavidDurhamMoore  DavidSan DiegoMoore  DavidPalo AltoAaron  DavidsonDirector DURHAMAaron  DavidsonMIAMIAaron  DavidsonDirector DURHAMWillard H  DereDirector THOUSAND OAKSS.E.C.  Desjardins-InnovatechMONTREAL, QUEBEC, CANADAASSOCIATES  DOMAINPRINCETONDomain Partners VI, L.P.10% Owner PRINCETONDomain Partners VIII, L.P.PRINCETONCorcoran  DonaldDurhamBRIAN H  DOVEY10% Owner PRINCETONDP VIII Associates, L.P.PRINCETONWeber  EckardPalo AltoWeber  EckardSan DiegoRichard I  EisenstadtVP, Finance & C.F.O. DURHAMRichard I  EisenstadtVP, Finance & CFO DURHAMLars  EkmanLA JOLLARousseau  FranckSan DiegoRousseau  FranckPalo AltoVipin K  GargPresident & C.E.O. DURHAMVipin K  GargPresident & CEO DURHAMBrenda D  GavinPHILADELPHIABrenda D  GavinDirector DURHAMLinda S  GraisPresident and CEO MENLO PARKLinda S  GraisPresident and CEO SAN DIEGOLinda S  GraisPresident and CEO PALO ALTOH.I.G. Ventures - Tranzyme, LLC10% Owner MIAMIBrian K  Halak10% Owner PRINCETONJAMES  HEALYMENLO PARKHIG GP II INCMIAMIJERYL L  HILLEMANSAN DIEGOJERYL L  HILLEMANCFO and Secretary PALO ALTOSTEVEN P  JAMESDirector Steven P  JamesDirector PALO ALTOCastaigne  Jean-PaulDurhamCastaigne  Jean-PaulSan DiegoCastaigne  Jean-PaulPalo AltoHilleman  JerylPalo AltoJOHN  JOHNSONDirector DURHAMJOHN  JOHNSONDirector DURHAMKim P.  KamdarPRINCETONNina S  KjellsonDirector MENLO PARKNina S  KjellsonDirector PALO ALTONina S  KjellsonDirector MENLO PARKNina S  KjellsonDirector MENLO PARKGordana  KosuticVP, Clinical and Regulatory DURHAMEkman  LarsSan DiegoEkman  LarsPalo AltoGrais  LindaSan DiegoGrais  LindaPalo AltoDana S.  McGowanCFO and Secretary SAN DIEGOPete  McNerneyMINNEAPOLISPete  McNerneyMINNEAPOLISPowell  MichaelSan DiegoPowell  MichaelPalo AltoSAMI  MNAYMNEHMIAMIDavid  MooreVP, Commercial Operations DURHAMDavid  MooreVP, Commercial Operations DURHAMKjellson  NinaSan DiegoKjellson  NinaPalo AltoRajiv  PatniChief Development Officer PALO ALTOMICHAEL  POWELLDirector MICHAEL  POWELLDirector MENLO PARKMICHAEL  POWELLDirector PALO ALTOShah  PratikSan DiegoShah  PratikPalo AltoQUAKER BIO VENTURES LP10% Owner PHILADELPHIAQUAKER BIOVENTURES CAPITAL LPPHILADELPHIAEisenstadt  RichardDurhamFRANCK  ROUSSEAUChief Medical Officer DURHAMFRANCK  ROUSSEAUChief Medical Officer DURHAMFRANCK  ROUSSEAUChief Medical & DEV Officer PALO ALTOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONNimesh  ShahPRINCETONPratik  ShahMINNEAPOLISPratik  ShahMINNEAPOLISPratik  ShahDirector PALO ALTOSofinnova Management VI, L.L.C.MENLO PARKSofinnova Venture Affiliates VI LPMENLO PARKSofinnova Venture Partners VI GmbH & Co. KGMENLO PARKSOFINNOVA VENTURE PARTNERS VI L P10% Owner MENLO PARKRhonda L.  StanleyDURHAMANTHONY  TAMERMIAMISHARON  TETLOWActing CFO & Treasurer PALO ALTOHelmut  ThomasSenior VP, R&D DURHAMHelmut  ThomasSenior VP, R&D DURHAMJAMES E  THOMASJAMES E  THOMASMINNEAPOLISJAMES E  THOMASMINNEAPOLISJAMES E  THOMASMINNEAPOLISThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II, LLCMINNEAPOLISThomas, McNerney & Partners II, LLCMINNEAPOLISThomas, McNerney & Partners, LLCMINNEAPOLISThomas, McNerney & Partners, LLCMINNEAPOLISThomas, McNerney & Partners, LLCMINNEAPOLISTHOMAS MCNERNEY & PARTNERS LPMINNEAPOLISTHOMAS MCNERNEY & PARTNERS LP10% Owner MINNEAPOLISTHOMAS MCNERNEY & PARTNERS LPMINNEAPOLISTMP Associates II LPMINNEAPOLISTMP Associates II LPMINNEAPOLISTMP Associates II LPMINNEAPOLISTMP ASSOCIATES LPMINNEAPOLISTMP ASSOCIATES LPMINNEAPOLISTMP ASSOCIATES LPMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISTMP Nominee, LLCMINNEAPOLISTMP Nominee, LLCMINNEAPOLISTMP Nominee, LLCMINNEAPOLISJESSE I  TREU10% Owner PRINCETONANNE  VANLENTDirector PRINCETONANNE  VANLENTDURHAMANNE  VANLENTDirector DURHAMANNE  VANLENTDirector DURHAMANNE  VANLENTDirector PALO ALTOGarg  VipinDurhamNICOLE  VITULLO10% Owner PRINCETONECKARD  WEBERDirector SOUTH SAN FRANCISCOECKARD  WEBERSAN DIEGOECKARD  WEBERDirector SAN DIEGOECKARD  WEBERDirector PALO ALTOWENDALL  WIERENGADirector PALO ALTOWENDALL D  WIERENGADirector SAN DIEGOAlex  ZissonMINNEAPOLISAlex  ZissonDirector DURHAMAlex  ZissonDirector DURHAMAlex  ZissonMINNEAPOLISPersons related to DP VI Associates, L.P. - Tobira Therapeutics, Inc.NamePositionCityplc  ActavisPARSIPPANYAllergan Holdco US, Inc.IRVINEGopka  AntonBasking RidgeClark  B.Basking Ridge3, FCPR  BIODISCOVERY10% Owner PARISBIOTECHNOLOGY VALUE FUND II LPCHICAGOBIOTECHNOLOGY VALUE FUND L PCHICAGOBIOTECHNOLOGY VALUE FUND L PCHICAGOJAMES C  BLAIR10% Owner PRINCETONCarol L  BrosgartDirector SOUTH SAN FRANCISCOBVF INC/ILCHICAGOBVF PARTNERS L P/IL CHICAGOCourts  ChrisBasking RidgeB. Jefferson  ClarkDirector BASKING RIDGEB. Jefferson  ClarkDirector BASKING RIDGEB. Jefferson  ClarkDirector BASKING RIDGEJeffrey H  CooperDirector NOVATOChristopher  CourtsVice President of Finance BASKING RIDGEChristopher  CourtsVice President of Finance BASKING RIDGEMazzo  DavidBasking RidgePodlesak  DennisBasking RidgeASSOCIATES  DOMAIN10% Owner PRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEYBRIAN H  DOVEY10% Owner PRINCETONDP VII ASSOCIATES LP10% Owner PRINCETONDe Rothschild Investment Partners  EdmondPARISR Don  ElseySr. VP/Chief Financial Officer BASKING RIDGER Don  ElseySr. VP/Chief Financial Officer BASKING RIDGELaurent  FischerChief Executive Officer WATERTOWNFrazier Healthcare V, LP10% Owner SEATTLEAndrew J.  FromkinDirector BASKING RIDGEAndrew J.  FromkinDirector BASKING RIDGEDrew J  FromkinDirector NEWTONAlexander R  GiaquintoCCO and SVP of Reg. Affairs BASKING RIDGEAlexander R  GiaquintoCCO, SVP of Reg. Affairs BASKING RIDGEAnton  GopkaDirector BASKING RIDGEAnton  GopkaDirector BASKING RIDGEAnton  GopkaDirector BASKING RIDGEBrian K  HalakPRINCETONPatrick J  HeronDirector PALO ALTOClark  JeffBasking RidgeHelen  JenkinsChief Operating Officer SOUTH SAN FRANCISCOTreu  JesseBasking RidgeKim P.  KamdarPRINCETONROBERT A  KIERLIN10% Owner WINONAROBERT A  KIERLIN10% Owner WINONAMARK N  LAMPERTSAN FRANCISCOEric  LefebvreChief Medical Officer SOUTH SAN FRANCISCOPierre  LegaultDirector BERKELEY HEIGHTSPierre  LegaultDirector BASKING RIDGEPierre  LegaultBASKING RIDGEDavid J  MazzoPresident and CEO BASKING RIDGEDavid J  MazzoChief Executive Officer BASKING RIDGEEllen  McDonaldSVP & Chief Business Officer BASKING RIDGEGwen A  MelincoffDirector SOUTH SAN FRANCISCOMichael  MendelsohnBASKING RIDGEMichael  MendelsohnDirector BASKING RIDGEMichael  MendelsohnDirector BASKING RIDGEMichael A  MetzgerPresident and COO BASKING RIDGEMichael A  MetzgerPresident & CEO BASKING RIDGEMendelsohn  MichaelBasking RidgeMetzger  MichaelBasking RidgeP SHERRILL  NEFFDirector BASKING RIDGEP SHERRILL  NEFFPHILADELPHIAP SHERRILL  NEFFDirector PHILADELPHIAA/S  Novo10% Owner BAGSVAERDNeff  P.Basking RidgeChristopher  PeetzChief Financial Officer SOUTH SAN FRANCISCONicholas J.  PelliccioneSr. VP of Regulatory Affairs BASKING RIDGEPentwater Capital Management LP10% Owner CHICAGOLegault  PierreBasking RidgeDennis  PodlesakDirector SAN DIEGODennis  PodlesakDirector BASKING RIDGEDennis  PodlesakDirector BASKING RIDGEDennis  PodlesakDirector BASKING RIDGEQUAKER BIO VENTURES LP10% Owner PHILADELPHIAQUAKER BIOVENTURES CAPITAL LPPHILADELPHIAWishiewski  RaphaelBasking RidgeWisniewski  RaphaelBasking RidgeInvestments S.a.r.l.  RMILUXEMBOURGInvestments S.a.r.l.  RMI10% Owner MOSCOWChristopher Paul  RusconiDURHAMChristopher Paul  RusconiChief Scientific Officer BASKING RIDGEChristopher Paul  RusconiChief Scientific Officer BASKING RIDGERusnanoMedInvest LLCMOSCOWRusnanoMedInvest LLCMOSCOWSapphire Acquisition Corp.PARSIPPANYKATHLEEN K  SCHOEMAKER10% Owner PRINCETONNimesh  ShahPRINCETONJESSE I  TREUDirector PRINCETONNICOLE  VITULLORICHMONDNICOLE  VITULLO10% Owner PRINCETONECKARD  WEBERDirector SOUTH SAN FRANCISCORaphael  WisniewskiDirector BASKING RIDGERaphael  WisniewskiDirector BASKING RIDGESteven  ZelenkofskeSVP & Chief Medical Officer BASKING RIDGESteven  ZelenkofskeSVP & Chief Medical Officer BASKING RIDGEPersons related to DP VI Associates, L.P. - Celator Pharmaceuticals IncNamePositionCityZisson  AlexStamfordZisson  AlexStamfordZisson  AlexPrincetonJEAN-PIERRE  BIZZARIDirector SAN DIEGOJAMES C  BLAIRPRINCETONGavin  BrendaPhiladelphiaGavin, D.V.M.  BrendaPhiladelphiaCAXTON CORPPRINCETONCAXTON CORPPRINCETONCDK ASSOCIATES, L.L.C.PRINCETONWood  DavidPrincetonWood  DavidPrincetonASSOCIATES  DOMAINPRINCETONDomain Partners VI, L.P.PRINCETONMICHAEL R  DOUGHERTYExecutive Chairman MICHAEL R  DOUGHERTYDirector EWINGMICHAEL R  DOUGHERTYDirector EWINGMICHAEL R  DOUGHERTYDirector EWINGBRIAN H  DOVEYPRINCETONPowell  FredPrincetonKenneth  GalbraithDirector PRINCETONGrowthWorks Capital Ltd.VANCOUVERBrian K  HalakPRINCETONBuchi  J.FrazerScott Thomas  JacksonChief Executive Officer PRINCETONScott Thomas  JacksonChief Executive Officer EWINGScott Thomas  JacksonChief Executive Officer EWINGScott Thomas  JacksonChief Executive Officer EWINGScott  JacksonPrincetonMollica  JosephPrincetonMollica  JosephPrincetonMolliica, Ph.D.  JosephPrincetonKim P.  KamdarPRINCETONGalbraith  KennethVancouverGalbraith  KennethVancouver, British ColumbiaGalbraith  KennethPrincetonRichard S  KollenderDirector PHILADELPHIARichard S  KollenderDirector PHILADELPHIARichard S  KollenderPHILADELPHIARichard S  KollenderPHILADELPHIARichard S  KollenderDirector PHILADELPHIABruce  Kovner NEW YORKBruce  Kovner PRINCETONMayer  LawrencePrincetonMayer  LawrencePrincetonMayer  LawrencePrincetonJoseph M  LobackiDirector ROCKVILLEJoseph M  LobackiDirector EWINGLawrence David  MayerSee Remarks PRINCETONLawrence David  MayerPresident and Head of Research EWINGLawrence David  MayerPresident and Head of Research EWINGJOSEPH A  MOLLICADirector JOSEPH A  MOLLICADirector PRINCETONJOSEPH A  MOLLICADirector EWINGScott D  MorensteinDirector NEW YORKScott D  MorensteinDirector NEW YORKScott D  MorensteinDirector NEW YORKScott D  MorensteinDirector NEW YORKVitullo  NicolePrincetonVitullo  NicolePrincetonVitullo  NicolePrincetonBrady  PatrickVancouverFred M  PowellVP and Chief Financial Officer PLYMOUTH MEETINGFred M  PowellV P & Chief Financial Officer PRINCETONFred M  PowellChief Financial Officer EWINGFred M  PowellChief Financial Officer EWINGFred M  PowellChief Financial Officer EWINGQUAKER BIO VENTURES LPPHILADELPHIAQUAKER BIO VENTURES LP10% Owner PHILADELPHIAQUAKER BIOVENTURES CAPITAL LPPHILADELPHIAQUAKER BIOVENTURES CAPITAL LPPHILADELPHIAKollender  RichardPrincetonEric W  RobertsNEW YORKKATHLEEN K  SCHOEMAKERPRINCETONJackson  ScottPrincetonJackson  ScottPrincetonMorenstein  ScottPrincetonThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II, LLCMINNEAPOLISTL VENTURES INCWAYNETL Ventures L.P.WAYNETL Ventures Manager LLCWAYNETL Ventures V Liquidating TrustWAYNETMP Associates II LPMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISJESSE I  TREUPRINCETONValence Advantage Life Sciences Fund II, L.P.NEW YORKValence Advantage Life Sciences Side Fund II, L.P.NEW YORKValence CDK SPV, L.P.NEW YORKValence Life Sciences GP II LLC NEW YORKVENTURES WEST CAPITAL LTD VANCOUVERNICOLE  VITULLODirector RICHMONDNICOLE  VITULLODirector PRINCETONDAVID  WOODPRINCETONAlex  ZissonDirector PRINCETONPersons related to DP VI Associates, L.P. - CADENCE PHARMACEUTICALS INCNamePositionCityHAZEL M  AKERSVP, GC & Secretary SAN DIEGOBRIAN G  ATWOODDirector SAN DIEGOBRIAN G  ATWOODDirector SAN DIEGOSAM L  BARKERSAN DIEGOSAM L  BARKERDirector SAN DIEGOMichael A  BermanDirector SAN DIEGOMichael A  BermanDirector SAN DIEGOJAMES C  BLAIRDirector PRINCETONJAMES B  BREITMEYEREVP, CMO SAN DIEGOScott A.  ByrdSVP, Chief Commercial Officer SAN DIEGOWILLIAM S  CRAIGSVP SAN DIEGOLAUREEN  DEBUONODirector SAN DIEGOASSOCIATES  DOMAIN10% Owner PRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VII ASSOCIATES LP10% Owner PRINCETONMICHAEL L  EAGLEDirector SAN DIEGOFHM V, LLCSEATTLEFHM V, LPSEATTLEFHM VI, L.L.C.SEATTLEFHM VI, L.P.SEATTLEALAN D  FRAZIERDirector SAN DIEGOFrazier Healthcare V, LP10% Owner SEATTLEFrazier Healthcare VI, L.P.SEATTLECAM L  GARNERDirector SAN DIEGOBrian K  Halak10% Owner PRINCETONKim P.  Kamdar10% Owner PRINCETONWILLIAM R  LARUESVP, CFO, Treas, Asst Sec SAN DIEGOMalcolm  Lloyd-SmithSVP, Reg Affairs, Qual & Clin SAN DIEGORichard E  LowenthalVP SAN DIEGOJay  MoorinPRINCETONJay  MoorinPRINCETONROBERT J  MORE10% Owner PRINCETONROBERT J  MOREPRINCETONStephen L  NewmanDirector SAN DIEGOProQuest Associates III LLCPRINCETONProQuest Associates III LLCPRINCETONProQuest Investments III, L.P.10% Owner PRINCETONProQuest Investments III, L.P.10% Owner PRINCETONProQuest Management LLCPRINCETONProQuest Management LLCPRINCETONProQuest Management LLCPRINCETONTodd W  RichDirector SAN DIEGOMike A  RoyalVP SAN DIEGOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONALAIN  SCHREIBERPRINCETONALAIN  SCHREIBERPRINCETONALAIN  SCHREIBERSAN DIEGOTheodore R  SchroederPresident, CEO SAN DIEGODavid A  SocksSVP SAN DIEGOJESSE I  TREU10% Owner PRINCETONJESSE I  TREU10% Owner PRINCETONCHRISTOPHER J  TWOMEYDirector SAN DIEGONICOLE  VITULLO10% Owner PRINCETONPersons related to DP VI Associates, L.P. - Pernix Sleep, Inc.NamePositionCityMichael D  AllenSVP, Sales and Marketing SAN DIEGOBA Venture Partners VI, LLCFOSTER CITYBAVP, L.P.10% Owner FOSTER CITYBAVP, L.P.10% Owner FOSTER CITYJAMES C  BLAIR10% Owner PRINCETONJAMES C  BLAIR10% Owner PRINCETONLOUIS C  BOCKDirector FOSTER CITYLOUIS C  BOCKFOSTER CITYLOUIS C  BOCKFOSTER CITYBoxer Asset Management Inc.NEW PROVIDENCEBoxer Asset Management Inc.NEW PROVIDENCEBoxer Capital, LLC DEL MARDorsey  BrianSolana BeachMark J  BrooksFOSTER CITYTerrell  CobbSAN DIEGOTerrell  CobbDirector SAN DIEGOTerrell  CobbDirector SAN DIEGOTerrell  CobbDirector SAN DIEGOTerrell  CobbDirector SAN DIEGOTerrell  CobbDirector SAN DIEGOTerrell  CobbDirector SOLANA BEACHKenneth M  CohenPresident and CEO SAN DIEGOKenneth M  CohenPresident and CEO SAN DIEGOHale  DavidSolana BeachMANAGEMENT CO /NY  DEERFIELDNEW YORKDeerfield Mgmt L.P.NEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations International Master Fund, L.P.NEW YORKASSOCIATES  DOMAINPRINCETONDomain Partners VI, L.P.10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONBrian  DorseyVP Product Development SAN DIEGOBrian  DorseySVP, Technical Operations SAN DIEGOBrian  DorseySVP, Technical Operations SAN DIEGOBrian  DorseySVP, Technical Operations SAN DIEGOBrian  DorseySVP, Technical Operations SAN DIEGOBrian  DorseySVP, Technical Operations SOLANA BEACHBRIAN H  DOVEY10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONSusan  DubeSenior VP, Corp and Bus Dev SAN DIEGOSusan  DubeSenior VP, Corp and Bus Dev SAN DIEGOMICHAEL L  EAGLEDirector SAN DIEGOMICHAEL L  EAGLEDirector SAN DIEGOMICHAEL L  EAGLEDirector SAN DIEGOMICHAEL L  EAGLEDirector SOLANA BEACHMICHAEL L  EAGLEDirector SAN DIEGOKURT VON  EMSTERDirector SAN DIEGOKURT VON  EMSTERDirector SOLANA BEACHKURT VON  EMSTERDirector SOUTH SAN FRANCISCOKURT VON  EMSTERBOSTONKURT VON  EMSTERDirector SAN DIEGOKURT VON  EMSTERDirector SOUTH SAN FRANCISCOKURT VON  EMSTERDirector SAN DIEGOKURT VON  EMSTERDirector SAN DIEGOMast  ErleSolana BeachLUKE  EVNIN10% Owner BOSTONJames E  FlynnNEW YORKANSBERT  GADICKEBOSTONANSBERT  GADICKEBOSTONNICHOLAS  GALAKATOSBOSTONNICHOLAS  GALAKATOSBOSTONCAM L  GARNERDirector SAN DIEGOCAM L  GARNERDirector SAN DIEGOCAM L  GARNERDirector SAN DIEGOSCOTT L  GLENNDirector SAN DIEGOSCOTT L  GLENNDirector SAN DIEGOSCOTT L  GLENNDirector SAN DIEGODAVID F  HALEDirector CARLSBADDAVID F  HALEDirector SAN DIEGODAVID F  HALEDirector SAN DIEGODAVID F  HALEDirector SOLANA BEACHDAVID F  HALEDirector SAN DIEGODAVID F  HALEExecutive Chairman SAN DIEGODAVID F  HALEDirector SAN DIEGOFaheem  HasnainDirector SAN DIEGOFaheem  HasnainDirector SAN DIEGOFaheem  HasnainDirector SOLANA BEACHDENNIS  HENNERBOSTONDENNIS  HENNERBOSTONRaser  JeffreySolana BeachTreu  JessePrincetonPhilip  JochelsonSenior VP and Chief Medical SAN DIEGOPhilip  JochelsonSenior VP and Chief Medical SAN DIEGOROBERT LEWIS  JONESVP of Human Resources SAN DIEGOWheeler  KurtSolana Beachvon Emster  KurtSolana BeachJOSEPH  LEWISNEW PROVIDENCEJOSEPH  LEWISNEW PROVIDENCEJAMES J  LITALIENSVP Regulatory Affairs & QA SAN DIEGOERLE T  MASTDirector SAN DIEGOERLE T  MASTDirector SOLANA BEACHERLE T  MASTDirector SAN DIEGOERLE T  MASTDirector SAN DIEGOERLE T  MASTDirector SAN DIEGOOnaitis  MatthewSolana BeachMeg  McGilleyVP, CFO, Treasurer, Secretary SAN DIEGOMeg  McGilleyVP, CFO, Treasurer SAN DIEGOEagle  MichaelSolana BeachKATE  MITCHELLFOSTER CITYMONTREUX EQUITY MANAGEMENT II SBIC LLCMENLO PARKMONTREUX EQUITY MANAGEMENT II SBIC LLCMENLO PARKEquity Managment SBIC  Montreux IIIMENLO PARKEquity Managment SBIC  Montreux IIIMENLO PARKMONTREUX EQUITY PARTNERS II SBIC LPMENLO PARKMONTREUX EQUITY PARTNERS II SBIC LP10% Owner MENLO PARKMONTREUX EQUITY PARTNERS III SBIC L PMENLO PARKMONTREUX EQUITY PARTNERS III SBIC L PROBERT J  MORE10% Owner PRINCETONROBERT J  MORE10% Owner PRINCETONMPM Asset Management Investors 2005 BVIII LLCBOSTONMPM Asset Management Investors 2005 BVIII LLCBOSTONMPM BIOVENTURES III GMBH & CO. Beteiligungs KGBOSTONMPM BIOVENTURES III GMBH & CO. Beteiligungs KGBOSTONMPM BIOVENTURES III GP L.P.BOSTONMPM BIOVENTURES III GP L.P.BOSTONMPM BIOVENTURES III GP LPBOSTONMPM BIOVENTURES III L.P.BOSTONMPM BIOVENTURES III L.P.BOSTONMPM BIOVENTURES III LLC10% Owner BOSTONMPM BIOVENTURES III LLCBOSTONMPM BIOVENTURES III LPBOSTONMPM BIOVENTURES III PARALLEL FUND, L.P.BOSTONMPM BIOVENTURES III PARALLEL FUND, L.P.BOSTONMPM BIOVENTURES III PARALLEL FUND, L.P.BOSTONMPM BIOVENTURES III PARALLEL FUND, LPBOSTONMPM BIOVENTURES III-QP L.P.10% Owner BOSTONMPM BIOVENTURES III-QP L.P.10% Owner BOSTONMPM BIOVENTURES III QP LP10% Owner BOSTONMVA Investors, LLCDEL MARTran  NguyenVice President and CFO SOLANA BEACHTran  NguyenSVP and CFO SAN DIEGOTran  NguyenSVP and CFO SAN DIEGOTran  NguyenSVP and CFO SAN DIEGOTran  NguyenSVP and CFO SOLANA BEACHTran  NguyenSVP and CFO SOLANA BEACHRory  O'DriscollFOSTER CITYMatthew  OnaitisVice President, Legal Affairs SAN DIEGOMatthew  OnaitisVP, General Counsel SAN DIEGOMatthew  OnaitisSVP, General Counsel SAN DIEGOMatthew  OnaitisSVP, General Counsel SAN DIEGOMatthew  OnaitisSVP, General Counsel SAN DIEGOMatthew  OnaitisSVP, General Counsel SAN DIEGOMatthew  OnaitisSVP, General Counsel SOLANA BEACHMatthew  OnaitisSVP, General Counsel SOLANA BEACHHOWARD D  PALEFSKYMENLO PARKHOWARD D  PALEFSKYMENLO PARKHOWARD D  PALEFSKYMENLO PARKRichard W  PascoePresident and CEO SAN DIEGORichard W  PascoePresident and CEO SAN DIEGORichard W  PascoePresident and CEO SAN DIEGORichard W  PascoePresident and CEO SAN DIEGORichard W  PascoePresident and CEO SAN DIEGORichard W  PascoePresident and CEO SOLANA BEACHJeffrey  RaserSenior VP, Sales and Marketing SAN DIEGOJeffrey  RaserSenior VP, Sales and Marketing SAN DIEGOJeffrey  RaserSVP, Chief Commercial Officer SAN DIEGOJeffrey  RaserSVP, Chief Commercial Officer SAN DIEGOPascoe  RichardSolana BeachScale Venture Management I, LLCFOSTER CITYKATHLEEN K  SCHOEMAKER10% Owner PRINCETONKATHLEEN K  SCHOEMAKER10% Owner PRINCETONNICHOLAS J  SIMON IIIBOSTONNICHOLAS J  SIMON IIIBOSTONMICHAEL  STEINMETZBOSTONMICHAEL  STEINMETZBOSTONCobb  TerrellSolana BeachWiggans  ThomasSolana BeachJESSE I  TREUDirector PRINCETONJESSE I  TREUDirector PRINCETONDANIEL K  TURNER IIIMENLO PARKDANIEL K  TURNER IIIMENLO PARKDANIEL K  TURNER IIIDirector SAN DIEGODANIEL K  TURNER IIIDirector SAN DIEGODANIEL K  TURNER IIIDirector SAN DIEGONICOLE  VITULLO10% Owner PRINCETONNICOLE  VITULLO10% Owner PRINCETONKURT  WHEELERDirector SAN DIEGOKURT  WHEELERDirector SAN DIEGOKURT  WHEELERBOSTONKURT  WHEELERDirector BOSTONKURT  WHEELERDirector SAN DIEGOTHOMAS G  WIGGANSDirector SAN DIEGOTHOMAS G  WIGGANSDirector SAN DIEGOTHOMAS G  WIGGANSDirector SAN DIEGOTHOMAS G  WIGGANSDirector SAN DIEGOPersons related to DP VI Associates, L.P. - Aldeyra Therapeutics, Inc.NamePositionCityXavier  AsishBurlingtonBronstein  BenBurlingtonBronstein  BenLexingtonJAMES C  BLAIRPRINCETONTodd C  BradyPresident and CEO SAN DIEGOTodd C  BradyPresident and CEO BURLINGTONBen  BronsteinDirector BURLINGTONClarke  C.BoydLexingtonBoyd  Clarke  C.LexingtonDavid J  ClarkChief Medical Officer LEXINGTONC. Boyd  ClarkeDirector BURLINGTONASSOCIATES  DOMAINPRINCETONDomain Partners VI, L.P.10% Owner PRINCETONRICHARD  DOUGLASDirector CAMBRIDGEBRIAN H  DOVEYPRINCETONJOSEPH  EDELMANPhillips  GaryBurlingtonPhillips  GaryLexingtonCagle  GeraldBurlingtonBrian K  HalakPRINCETONTreu  JesseLexingtonDowling  JohnBurlingtonJOHNSON & JOHNSON10% Owner NEW BRUNSWICKJOHNSON & JOHNSON DEVELOPMENT CORP ET ALNEW BRUNSWICKMARTIN JOSEPH  JOYCEDirector ROCKLANDMARTIN JOSEPH  JOYCEDirector BURLINGTONKim P.  KamdarPRINCETONJoyce  MartinLexingtonWalker  NealLexingtonPERCEPTIVE ADVISORS LLC10% Owner WASHINGTONPERCEPTIVE LIFE SCIENCES MASTER FUND LTDWASHINGTONGARY M  PHILLIPSDirector ROCHESTERGary M.  PhillipsDirector BURLINGTONKATHLEEN K  SCHOEMAKERPRINCETONYoung  ScottLexingtonNimesh  ShahPRINCETONTulipano  StephenLexingtonBrady  ToddBurlingtonBrady  ToddLexingtonJESSE I  TREUDirector PRINCETONStephen J  TulipanoChief Financial Officer CAMBRIDGEStephen J  TulipanoChief Financial Officer BURLINGTONNICOLE  VITULLOPRINCETONNeal  WalkerDirector BURLINGTONSCOTT  YOUNGChief Operating Officer WALTHAMSCOTT  YOUNGBURLINGTONPersons related to DP VI Associates, L.P. - Vanda Pharmaceuticals Inc.NamePositionCityALEXANDER E  BARKASPALO ALTOPaolo  BaroldiSVP & Chief Medical Officer ROCKVILLEPaolo  BaroldiSVP & Chief Medical Officer WASHINGTONKENNETH  BATEDirector CAMBRIDGE,Bio One Capital Pte Ltd.SINGAPOREBio One Capital Pte Ltd.CENTROSBiomedical Sciences Investment Fund Pte Ltd.10% Owner SINGAPOREBiomedical Sciences Investment Fund Pte Ltd.10% Owner CENTROSGunther  BirznieksWASHINGTONJAMES C  BLAIR10% Owner PRINCETONCARE CAPITAL  II  LLC10% Owner PRINCETONCARE CAPITAL  II  LLC10% Owner PRINCETONCARE CAPITAL INVESTMENTS II LPPRINCETONCARE CAPITAL INVESTMENTS II LPPRINCETONCare Capital Offshore Investments II LPPRINCETONCare Capital Offshore Investments II LPPRINCETONWilliam D  ClarkROCKVILLEWilliam D  ClarkSr. VP, Chief Business Officer ROCKVILLEMICHAEL F  COLADirector WAYNEMICHAEL F  COLADirector WASHINGTONThomas Lyle  CopmannROCKVILLEDEERFIELD CAPITAL LP ET ALNEW YORKDeerfield International Master Fund, L.P.NEW YORKDeerfield International Master Fund, L.P.NEW YORKMANAGEMENT CO  DEERFIELDNEW YORKMANAGEMENT CO /NY  DEERFIELDDeerfield Mgmt L.P.NEW YORKDEERFIELD PARTNERS, LPNEW YORKDEERFIELD PARTNERS, LPNEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations Fund, L.P.NEW YORKDeerfield Special Situations International Master Fund, L.P.NEW YORKDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONRICHARD W  DUGANDirector GERMANTOWNRICHARD W  DUGANDirector SCOTTSDALERICHARD W  DUGANDirector GIBSONIA, PA 15044EDB Investments Pte Ltd.SINGAPOREEDB Investments Pte Ltd.CENTROSJohn Joseph  FeeneySVP & Chief Medical Officer ROCKVILLEJohn Joseph  FeeneyWASHINGTONJames E  Flynn10% Owner NEW YORKJames E  Flynn10% Owner NEW YORKSteven K  GalsonDirector ROCKVILLESteven K  GalsonDirector WASHINGTONAlbert W.  GianchettiSr.VP,Chief Commercial Officer ROCKVILLEThomas Edward  GibbsSVP, Chief Commercial Officer WASHINGTONRichard L.  GulinoSVP, General Counsel & Sec. WASHINGTONBrian K  HalakDirector PRINCETONRUSSELL C  HIRSCHPALO ALTOWAYNE T  HOCKMEYERDirector GAITHERSBURGStephanie Rast  IrishActing CFO/Treasurer ROCKVILLEHABIB  KAIROUZNEW YORKHABIB  KAIROUZNEW YORKARGERIS N  KARABELASDirector PRINCETONJames Patrick  KellyEVP & Chief Financial Officer ROCKVILLEJames Patrick  KellySVP, CFO, Sec & Treasurer WASHINGTONJAN  LESCHLYPRINCETONJAN  LESCHLYPRINCETONMARK  LESCHLYNEW YORKMARK  LESCHLYNEW YORKMEDIMMUNE INC /DE10% Owner GAITHERSBURGVINCENT  MILANODirector VINCENT  MILANODirector EXTONVINCENT  MILANODirector WASHINGTONROBERT J  MORE10% Owner PRINCETONDeepak Shripad  PhadkeVice President Manufacturing ROCKVILLEHOWARD H  PIENDirector EMERYVILLEHOWARD H  PIENDirector ROCKVILLEMihael Hristos  PolymeropoulosPresident and CEO ROCKVILLEMihael Hristos  PolymeropoulosPresident and CEO WASHINGTONPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT MANAGEMENT CO II LLC10% Owner PALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT VENTURE PARTNERS II LPPALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTODavid Russ  RamsayDirector PRINCETONDavid Russ  RamsayDirector PRINCETONRobert  RepellaSVP & Chief Commercial Officer ROCKVILLERobert  RepellaSVP & Chief Commercial Officer WASHINGTONGian Piero  ReverberiSVP & Chief Commercial Officer WASHINGTONRHO CAPITAL PARTNERS INCNEW YORKRHO CAPITAL PARTNERS INCNEW YORKCAPITAL PARTNERS VERWALTUNGS GMBH  RHONEW YORKCAPITAL PARTNERS VERWALTUNGS GMBH  RHONEW YORKRHO MANAGEMENT TRUST INEW YORKRHO MANAGEMENT TRUST INEW YORKRHO MANAGEMENT VENTURES IV LLCNEW YORKRHO MANAGEMENT VENTURES IV LLCNEW YORKRHO VENTURES IV GMBH & CO BETEILIGUNGS KGNEW YORKRHO VENTURES IV GMBH & CO BETEILIGUNGS KGNEW YORKRHO VENTURES IV LP10% Owner NEW YORKRHO VENTURES IV LP10% Owner NEW YORKRHO VENTURES IV QP LPNEW YORKRHO VENTURES IV QP LPNEW YORKJOSHUA  RUCHNEW YORKJOSHUA  RUCHNEW YORKDAVID  SCHNELLPALO ALTOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONSTEVEN A  SHALLCROSSSr. VP, CFO, Treasurer ROCKVILLESTEVEN A  SHALLCROSSSr. VP, CFO, Treasurer ROCKVILLEJAMES B  TANANBAUMDirector PALO ALTOJAMES B  TANANBAUMDirector PALO ALTOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL PARTNERS LPSAN DIEGOKEVIN C  TANG10% Owner SAN DIEGOJESSE I  TREU10% Owner PRINCETONNICOLE  VITULLO10% Owner PRINCETONThomas  WatkinsDirector ROCKVILLEThomas  WatkinsDirector LAKE FORESTPersons related to DP VI Associates, L.P. - CoLucid Pharmaceuticals, Inc.NamePositionCityA.M. Pappas & Associates, LLCRESEARCH TRIANGLE PARKA.M. Pappas Life Science Ventures III, L.P.RESEARCH TRIANGLE PARKPappas  ArthurDurhamKuca  BerniceDurhamJAMES C  BLAIRPRINCETONCare Capital III LLCPRINCETONCare Capital Investments III L.P.PRINCETONCare Capital Offshore Investments III LPPRINCETONMARK  CORRIGANDirector MARLBOROUGHMatthew D  DallasChief Financial Officer CAMBRIDGEBoeglin  DanielIndianapolisDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEYMartin  EdwardsBURLINGTONLinda C.  HoganHead, Bus. Dev. and Strategy BURLINGTONWhite  JamesDurhamTreu  JessePrincetonBernice  KucaHead,Clin. and Reg. Operations BURLINGTONALISON FRANCIS  LAWTONDirector LEXINGTONLILLY ELI & CO10% Owner INDIANAPOLISMarengere  LucWestmountLuc  MarengereDirector BURLINGTONRichard J  MarkhamDirector PRINCETONEdwards  MartinHellerupThomas  MathersDurhamThomas  MathersDurhamThomas P.  MathersChief Executive Officer BURLINGTONRupniak  NadiaDurhamRupniak  NadiaDurhamA/S  Novo10% Owner BAGSVAERDARTHUR M  PAPPASDirector ProCar Acquisition CorpINDIANAPOLISPV III CEO Fund, L.P.RESEARCH TRIANGLE PARKMarkham  RichardPrincetonNadia  RupniakVP-Research and Development BURLINGTONKATHLEEN K  SCHOEMAKERPRINCETONRaymond  SkwierczynskiHead,Pharmaceutical Operations CAMBRIDGEMathers  ThomasDurhamGupton  TimothyRaleighJESSE I  TREUDirector PRINCETONTVM Life Science Ventures VII L.P.MONTREALNICOLE  VITULLORICHMONDMarvin L  WhiteDirector ROCKVILLEPersons related to DP VI Associates, L.P. - ZOGENIX, INC.NamePositionCityZisson  AlexMinneapolisRhoads  AnnSan DiegoMinocherhomjee  ArdaChicagoMinocherhomjee, Ph.D.  ArdaSan DiegoJAMES C  BLAIRDirector PRINCETONLOUIS C  BOCKDirector FOSTER CITYLOUIS C  BOCKDirector FOSTER CITYLOUIS C  BOCKDirector FOSTER CITYJAMES B  BREITMEYERDirector SAN DIEGOJAMES B  BREITMEYERDirector SAN DIEGOMark J  BrooksFOSTER CITYGarner  CamSan DiegoGarner  CamSan DiegoChicago Growth Management II, LLCCHICAGOChicago Growth Management II, LLCCHICAGOChicago Growth Management II, LLCCHICAGOChicago Growth Management II, LPCHICAGOChicago Growth Management II, LPCHICAGOChicago Growth Partners II L PCHICAGOChicago Growth Partners II L P CHICAGOClarus Lifesciences I, L.P.10% Owner CAMBRIDGEClarus Lifesciences I, L.P.10% Owner CAMBRIDGEClarus Ventures I, LLCCAMBRIDGEClarus Ventures I, LLCCAMBRIDGEClarus Ventures I Management, L.P.CAMBRIDGEClarus Ventures I Management, L.P.CAMBRIDGERobinson  CynthiaSan DiegoThierry J.P.  DarcisEVP / General Manager, Europe SAN DIEGONassif  DavidSan DiegoASSOCIATES  DOMAINPRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONDomain Partners VI, L.P.PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VII ASSOCIATES LP10% Owner PRINCETONJOSEPH  EDELMANMast  ErleSan DiegoMast  ErleSan DiegoGail M  FarfelEVP/Chief Development Officer NEW HAVENSTEPHEN J  FARRPresident and CEO HAYWARDSTEPHEN J  FARRSAN DIEGOSTEPHEN J  FARRPresident and COO SAN DIEGOSTEPHEN J  FARRPresident and COO SAN DIEGONICHOLAS  GALAKATOSCAMBRIDGENICHOLAS  GALAKATOSCAMBRIDGEBradley S.  GalerEVP/Chief Medical Officer SAN DIEGOCAM L  GARNERDirector CARLSBADCAM L  GARNERDirector SAN DIEGOCAM L  GARNERDirector SAN DIEGOKen  HaasDirector MENLO PARKBrian K  Halak10% Owner PRINCETONROGER  HAWLEYDirector BRISBANEROGER  HAWLEYChief Executive Officer SAN DIEGOROGER  HAWLEYChief Executive Officer SAN DIEGODENNIS  HENNERCAMBRIDGEDENNIS  HENNERCAMBRIDGEHaldeman  J.D.San DiegoBLAIR  JAMESPRINCETONKim P.  KamdarPRINCETONHaas  KenSan DiegoHaas  KenMenlo ParkWheeler  KurtCambridgeROBERT  LIPTAKCAMBRIDGEROBERT  LIPTAKCAMBRIDGEBock  LouisFoster CityERLE T  MASTDirector BOULDERERLE T  MASTDirector SAN DIEGOERLE T  MASTSAN DIEGOERLE T  MASTDirector SAN DIEGOPete  McNerneyMINNEAPOLISARDA PHD  MINOCHERHOMJEEDirector CHICAGOARDA PHD  MINOCHERHOMJEECHICAGOKATE  MITCHELLFOSTER CITYRory  O'DriscollFOSTER CITYPERCEPTIVE ADVISORS LLCWASHINGTONPERCEPTIVE LIFE SCIENCES MASTER FUND LTDWASHINGTONANN D  RHOADSEVP, CFO, Treasurer & Sec. SAN JOSEANN D  RHOADSEVP, CFO, Treasurer & Sec. SAN DIEGOANN D  RHOADSEVP, CFO, Treasurer & Sec. SAN DIEGOCynthia Y  RobinsonChief Development Officer SAN DIEGOCynthia Y  RobinsonChief Development Officer SAN DIEGOHawley  RogerSan DiegoScale Venture Management II, LLCFOSTER CITYScale Venture Partners II, LP10% Owner FOSTER CITYKATHLEEN K  SCHOEMAKER10% Owner PRINCETONRichard Scott  ShivelyChief Commercial Officer SAN DIEGONicholas  SimonCAMBRIDGENicholas  SimonCAMBRIDGEMichael P  SmithEVP, CFO, Treasurer & Sec. VANCOUVERMICHAEL  STEINMETZCAMBRIDGEMICHAEL  STEINMETZCAMBRIDGEFarr  StephenSan DiegoRENEE P  TANNENBAUMDirector SAN DIEGOJAMES E  THOMASMINNEAPOLISThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II, LLCMINNEAPOLISThomas, McNerney & Partners, LLCMINNEAPOLISTHOMAS MCNERNEY & PARTNERS LP MINNEAPOLISTMP Associates II LPMINNEAPOLISTMP ASSOCIATES LPMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISTMP Nominee, LLCMINNEAPOLISJESSE I  TREU10% Owner PRINCETONNICOLE  VITULLO10% Owner PRINCETONKURT  WHEELERDirector CAMBRIDGEKURT  WHEELERDirector CAMBRIDGESharon L  WienbarFOSTER CITYMARK C  WIGGINSDirector SAN DIEGOMARK C  WIGGINSDirector SAN DIEGOMARK C  WIGGINSDirector SAN DIEGOPersons related to DP VI Associates, L.P. - Syndax Pharmaceuticals IncNamePositionCityMorris  ArleneWalthamMorris  ArleneWalthamJAMES C  BLAIRPRINCETONMorrison, M.D.  BriggsWalthamHenry  Chen WALTHAMPodlesak  DennisWalthamPodlesak  DennisWalthamPodlesak  DennisWalthamASSOCIATES  DOMAINPRINCETONDomain Partners VI, L.P.10% Owner PRINCETONDomain Partners VIII, L.P.10% Owner PRINCETONBRIAN H  DOVEYDP VIII Associates, L.P.10% Owner BOSTONFabrice  Egros WALTHAMLUKE  EVNINDirector BOSTONEgros  FabriceWalthamEgros, Ph.D.  FabriceWalthamEgros, Ph.D.  FabriceWalthamTodd  FoleyCAMBRIDGEANSBERT  GADICKEBOSTONSledge, Jr. M.D.  GeorgeWalthamSledge, Jr., M.D.  GeorgeWalthamBrian K  HalakPRINCETONChen  HenryWalthamRoyston  IvorWalthamRoyston  IvorWalthamRoyston, M.D.  IvorWalthamHorobin, M.D.  JoannaWalthamPallies  JohnWalthamPallies  JohnWalthamVAUGHN M  KAILIANKim P.  KamdarDirector PRINCETONKeith  Katkin SAN DIEGOKamdar, Ph.D.  KimWalthamKamdar, Ph.D.  KimWalthamKamdar, Ph.D  KimWalthamKamdar, Ph.D  KimWalthamKamdar, PhD  KimWalthamPierre  Legault BERKELEY HEIGHTSEvnin, Ph.D.  LukeWalthamEvnin, Ph.D.  LukeWalthamMichael A  MetzgerPresident and COO LOS ANGELESMichael L.  MeyersSVP, Chief Medical Officer WALTHAMMetzger  MichaelWalthamBriggs  MorrisonChief Executive Officer WALTHAMMPM Asset Management Investors BV4 LLCBOSTONMPM BioVentures IV GmbH & Co. Beteiligungs KGBOSTONMPM BioVentures IV GP LLCBOSTONMPM BioVentures IV LLCBOSTONMPM BioVentures IV QP LP10% Owner BOSTONMPM BioVentures IV Strategic Fund, L.P.BOSTONPeter  OrdentlichChief Scientific Officer WALTHAMDennis  Podlesak SAN DIEGOShea  RichardWalthamGoodenow, Ph.D.  RobertWalthamGoodenow, PhD  RobertWalthamMaar Pavia, M.D.  RosinaWalthamIVOR  ROYSTONDirector James Paul  ScopaS. SAN FRANCISCONimesh  ShahPRINCETONAllan  ShawNEW YORKRichard P  SheaChief Financial Officer CAMBRIDGEGeorge W. Jr.  Sledge WALTHAMSt. Peter, M.D.  StevenWalthamJESSE I  TREUPRINCETONNICOLE  VITULLORICHMOND












 









 SECGems: DP VIII Associates, L.P. 







































  







			Data feeds now available
			Excel / CSV / Java / Python /etc 
Database
Learn more









  




  


  






























 DP VIII Associates, L.P. 
		     










 Info




 Ownership




 Filings
21















←


 1 


→



 Filings:    (1 of 20 - Total: 21)









		
			April 12, 2017 .
		
	


				Issuer
			

 
					Dicerna Pharmaceuticals Inc 
					

 
					DRNA
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					        Director,               
					
					
					
					
					]
				

Signed By

 Lisa A Kraeutler as Attorney-in-Fact for DP VIII Associates LP J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-17-000306.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				April 11, 2017 
			







Redeemable Convertible Preferred Stock 


 
 	[P : Open market or private purchase] 
 	 368 
shares 
  
 
 
 	x 
 	$100.00/sh
Total owned:
368 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	11,536 shares













		
			March 8, 2016 .
		
	


				Issuer
			

 
					Syndax Pharmaceuticals Inc 
					

 
					SNDX
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Lisa A Kraeutler as Attorney-in-Fact for DP VIII Associates LP J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-16-001107.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				March 8, 2016 
			







Common Stock 


 
 	[C : Deriv security conv] 
 	 5,641 
shares
Total owned:
5,641


Series B-1 Preferred Stock 


 
 	[C : Deriv security conv] 
 	 2,967 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	2,967 shares


Series C-1 Preferred Stock 


 
 	[C : Deriv security conv] 
 	 2,674 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	2,674 shares













		
			March 2, 2016 .
		
	


				Issuer
			

 
					Syndax Pharmaceuticals Inc 
					

 
					SNDX
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Lisa A Kraeutler as Attorney-in-Fact for DP VIII Associates LP J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-16-001085.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				March 2, 2016 
			







Series B-1 Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	2,967 shares


Series C-1 Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	2,674 shares













		
			July 1, 2015 .
		
	


				Issuer
			

 
					GLAUKOS Corp 
					

 
					GKOS
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					SCHOEMAKER KATHLEEN K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker as Managing Member of One Palmer Square Associates VIII LLC GP of DP VIII Associates LP individually and as Attorney-in-Fact for J Blair B Dovey J Treu N Vitullo and BHalak






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-15-000441.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				June 30, 2015 
			







Common Stock 


 
 	[C : Deriv security conv] 
 	 6,501 
shares
Total owned:
6,501


Series E Preferred Stock 


 
 	[C : Deriv security conv] 
 	 4,371 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	4,371 shares


Series F Preferred Stock 


 
 	[C : Deriv security conv] 
 	 2,130 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	2,130 shares













		
			June 24, 2015 .
		
	


				Issuer
			

 
					GLAUKOS Corp 
					

 
					GKOS
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					SCHOEMAKER KATHLEEN K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker as Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP individually and as Attorney-in-Fact for J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-15-000426.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				June 24, 2015 
			







Series E Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	4,371 shares


Series F Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	2,130 shares













		
			May 12, 2015 .
		
	


				Issuer
			

 
					aTYR PHARMA INC 
					

 
					LIFE
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					        Director,               
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					SCHOEMAKER KATHLEEN K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker as Managing Member of One Palmer Square Associates VIII LLC the general partner of DP VIII Associates LP individually and as Attorney-in-Fact for J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-15-000288.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				May 12, 2015 
			







Common Stock 


 
 	[C : Deriv security conv] 
 	 13,414 
shares
Total owned:
13,414


Series C Preferred Stock 


 
 	[C : Deriv security conv] 
 	 90,110 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	11,329 shares


Series D Preferred Stock 


 
 	[C : Deriv security conv] 
 	 11,182 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	1,405 shares


Series E Preferred Stock 


 
 	[C : Deriv security conv] 
 	 6,581 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	680 shares













		
			May 6, 2015 .
		
	


				Issuer
			

 
					aTYR PHARMA INC 
					

 
					LIFE
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					        Director,               
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					SCHOEMAKER KATHLEEN K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker as Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP individually and as Attorney-in-Fact for J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-15-000270.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				May 6, 2015 
			







Series C Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	90,110 shares


Series D Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	11,182 shares


Series E Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	6,581 shares













		
			Nov. 18, 2014 .
		
	


				Issuer
			

 
					Durata Therapeutics, Inc. 
					

 
					DRTX
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					SCHOEMAKER KATHLEEN K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					        Director,               
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker as Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP individually and as Attorney-in-Fact for J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-14-000757.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Nov. 17, 2014 
			







Common Stock 


 
 	[D : Disp to issuer] 
 	 22,306 
shares
Total owned:
0













		
			Oct. 21, 2014 .
		
	


				Issuer
			

 
					Atara Biotherapeutics, Inc. 
					

 
					ATRA
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					SCHOEMAKER KATHLEEN K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker as Managing Member of One Palmer Square Associates VIII LLC the general partner of DP VIII Associates LP individually and as Attorney-in-Fact for J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-14-000721.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Oct. 21, 2014 
			







Common Stock 


 
 	[C : Deriv security conv] 
 	 14,049 
shares
Total owned:
14,049


Common Stock 


 
 	[P : Open market or private purchase] 
 	 1,841 
shares 
  
 
 
 	x 
 	$11.00/sh
Total owned:
15,890


Series A Preferred Stock 


 
 	[C : Deriv security conv] 
 	 9,443 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	9,443 shares


Series B Preferred Stock 


 
 	[C : Deriv security conv] 
 	 4,606 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	4,606 shares













		
			Oct. 15, 2014 .
		
	


				Issuer
			

 
					Atara Biotherapeutics, Inc. 
					

 
					ATRA
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					SCHOEMAKER KATHLEEN K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker as Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP individually and as Attorney-in-Fact for J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-14-000711.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Oct. 15, 2014 
			







Series A Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	9,443 shares


Series B Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	4,606 shares













		
			Aug. 18, 2014 .
		
	


				Issuer
			

 
					Otonomy, Inc. 
					

 
					OTIC
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Domain Partners VIII, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					        Director,               
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					SCHOEMAKER KATHLEEN K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker as Managing Member of One Palmer Square Associates VIII LLC the general partner of DP VIII Associates LP individually and as Attorney-in-Fact for J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-14-000590.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Aug. 18, 2014 
			







Common Stock 


 
 	[C : Deriv security conv] 
 	 11,490 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
11,490


Common Stock 


 
 	[M : Exer. or conv. of deriv. security exempted] 
 	 502 
shares 
  
 
 
 	x 
 	$8.79/sh
Total owned:
11,992


Common Stock 


 
 	[F : Pmt of exercise price or tax liab] 
 	 277 
shares 
  
 
 
 	x 
 	$16.00/sh
Total owned:
11,715


Series B Preferred Stock 


 
 	[C : Deriv security conv] 
 	 3,238 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	3,238 shares


Series C Preferred Stock 


 
 	[C : Deriv security conv] 
 	 6,866 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	6,866 shares


Series D Preferred Stock 


 
 	[F : Pmt of exercise price or tax liab] 
 	 1,386 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	1,386 shares


Series C Preferred Stock Warrant (Right to Buy) 


 
 	[M : Exer. or conv. of deriv. security exempted] 
 	 502 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	502 shares













		
			Aug. 12, 2014 .
		
	


				Issuer
			

 
					Otonomy, Inc. 
					

 
					OTIC
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					BLAIR JAMES C 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					DOVEY BRIAN H 
					


					[
					      10% owner,              
					        Director,               
					
					
					
					
					]
				


 
					TREU JESSE I 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					SCHOEMAKER KATHLEEN K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					VITULLO NICOLE 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				


 
					Halak Brian K 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker as Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP individually and as Attorney-in-Fact for J Blair B Dovey J Treu N Vitullo and B Halak






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-14-000576.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Aug. 12, 2014 
			







Series B Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	3,238 shares


Series C Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	6,866 shares


Series D Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	1,386 shares


Warrant to Purchase Series C Preferred Stock (Right to Buy) 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	502 shares













		
			Feb. 4, 2014 .
		
	


				Issuer
			

 
					Dicerna Pharmaceuticals Inc 
					

 
					DRNA
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-14-000123.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Feb. 4, 2014 
			







Common Stock 


 
 	[C : Deriv security conv] 
 	 13,004 
shares
Total owned:
13,004


Series B Preferred Stock 


 
 	[C : Deriv security conv] 
 	 3,535 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	3,535 shares


Series C Preferred Stock 


 
 	[C : Deriv security conv] 
 	 9,469 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	9,469 shares


Warrant 


 
 	[C : Deriv security conv] 
 	 156 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Series C Preferred Stock ]
 
 
 
 	156 shares


Warrant 


 
 	[C : Deriv security conv] 
 	 156 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
156 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	156 shares













		
			Jan. 29, 2014 .
		
	


				Issuer
			

 
					Dicerna Pharmaceuticals Inc 
					

 
					DRNA
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-14-000103.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Jan. 29, 2014 
			







Series B Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	3,535 shares


Series C Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	9,469 shares


Warrant 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Series C Preferred Stock ]
 
 
 
 	156 shares













		
			Nov. 4, 2013 .
		
	


				Issuer
			

 
					VERACYTE, INC. 
					

 
					VCYT
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-13-001147.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Nov. 4, 2013 
			







Common Stock 


 
 	[C : Deriv security conv] 
 	 22,730 
shares
Total owned:
22,730


Series B Preferred Stock 


 
 	[C : Deriv security conv] 
 	 17,677 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	17,677 shares


Series C Preferred Stock 


 
 	[C : Deriv security conv] 
 	 5,053 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	5,053 shares













		
			Oct. 29, 2013 .
		
	


				Issuer
			

 
					VERACYTE, INC. 
					

 
					VCYT
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-13-001127.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Oct. 29, 2013 
			







Series B Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	17,677 shares


Series C Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	5,053 shares













		
			July 16, 2013 .
		
	


				Issuer
			

 
					Ocera Therapeutics, Inc. 
					

 
					OCRX
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-13-000792.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				July 15, 2013 
			







Common Stock 


Total owned:
7,333













		
			July 24, 2012 .
		
	


				Issuer
			

 
					Durata Therapeutics, Inc. 
					

 
					DRTX
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP






		Preview. 
	

 
			View filing ...
		






				4
			




 
					0000904454-12-000370.nc
				

 
					XML (1) 
				





					Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				July 24, 2012 
			







Common Stock 


 
 	[C : Deriv security conv] 
 	 16,529 
shares
Total owned:
16,529


Common Stock 


 
 	[P : Open market or private purchase] 
 	 5,777 
shares 
  
 
 
 	x 
 	$9.00/sh
Total owned:
22,306


Series A Preferred Stock 


 
 	[C : Deriv security conv] 
 	 16,529 
shares 
  
 
 
 	x 
 	$0/sh
Total owned:
0 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	16,529 shares













		
			July 18, 2012 .
		
	


				Issuer
			

 
					Durata Therapeutics, Inc. 
					

 
					DRTX
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-12-000358.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				July 18, 2012 
			







Series A Preferred Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	16,529 shares













		
			Aug. 23, 2010 .
		
	


				Issuer
			

 
					ACHILLION PHARMACEUTICALS INC 
					

 
					ACHN
				


				Reporting Owner
			

 
					DP VIII Associates, L.P. 
					


					[
					      10% owner,              
					
					
					
					
					
					]
				

Signed By

 Kathleen K Schoemaker Managing Member of One Palmer Square Associates VIII LLC General Partner of DP VIII Associates LP






		Preview. 
	

 
			View filing ...
		






				3
			




 
					0000904454-10-000282.nc
				

 
					XML (1) 
				





					Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
				






				Period ending 
			

				Aug. 20, 2010 
			







Common Stock 


Total owned:
59,161


Warrants to Purchase Common Stock 


  
 
 
 
 
 
 
 
 
 
 
 	[ Underlying Securities: Common Stock ]
 
 
 
 	20,706 shares










 





db
 
 



















































DP VII ASSOCIATES LP Insider Insider Trades - NASDAQ.com



























































Hot Topics:
ETFs |
Smart Portfolio |
Currencies |
Online Broker Center















Search






















Home > 
    Quotes > 
    Ownership & Insider Trades > 
    Individual Insiders






Insider Trades of DP VII ASSOCIATES LP





Click on the column header to resort ascending (▲) or descending (▼).



Individual Insider Trades



Company


Relation


Last Date ▼


Type


Tran


OwnerType


Shares Traded


Last Price


Shares Held



OBALON THERAPEUTICS INC
Beneficial Owner (10%)
10/12/2016
Form 4
Acquisition (Non Open Market)
direct
49,570
0
49,570


EVOKE PHARMA INC
Beneficial Owner (10%)
05/26/2016
Form 4
Sell
direct
5,880
4.7
10,328


EVOKE PHARMA INC
Beneficial Owner (10%)
04/27/2016
Form 4
Sell
direct
61
5.02
16,208


EVOKE PHARMA INC
Beneficial Owner (10%)
04/25/2016
Form 4
Sell
direct
21
5.2
16,269


EVOKE PHARMA INC
Beneficial Owner (10%)
04/20/2016
Form 4
Sell
direct
76
5.29
16,290


EVOKE PHARMA INC
Beneficial Owner (10%)
04/19/2016
Form 4
Sell
direct
632
5.36
16,366


EVOKE PHARMA INC
Beneficial Owner (10%)
04/11/2016
Form 4
Sell
direct
75
5.22
16,998


EVOKE PHARMA INC
Beneficial Owner (10%)
04/08/2016
Form 4
Sell
direct
251
5.35
17,073


EVOKE PHARMA INC
Beneficial Owner (10%)
04/07/2016
Form 4
Sell
direct
475
5.26
17,324


EVOKE PHARMA INC
Beneficial Owner (10%)
04/06/2016
Form 4
Sell
direct
148
5.22
17,799


EVOKE PHARMA INC
Beneficial Owner (10%)
08/18/2015
Form 4
Sell
direct
202
7.02
17,947















Highest Rated Articles of Last Week



Shareholders Approve Major Structural Change to Top Performing...
Yatra Attains Leadership Position in Corporate Travel With the...
Miller Heiman Group Selects CallidusCloud Datahug for Pipeline...
Tractor Supply Company Reports Second Quarter Results
Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon





View All Highest Rated































Most Rated Stocks of Last Week
Rated stocks for NASDAQ, NYSE and AMEX

Symbol  /  Ratings Consensus

AAPL

86% bullish
                    of
                    2911
                    ratings
Rate It


FB

76% bullish
                    of
                    1327
                    ratings
Rate It


MSFT

84% bullish
                    of
                    649
                    ratings
Rate It


TSLA

78% bullish
                    of
                    587
                    ratings
Rate It


NVDA

82% bullish
                    of
                    131
                    ratings
Rate It


GOOG

91% bullish
                    of
                    128
                    ratings
Rate It


JPM

70% bullish
                    of
                    88
                    ratings
Rate It


GM

68% bullish
                    of
                    80
                    ratings
Rate It


BAC

75% bullish
                    of
                    474
                    ratings
Rate It


INTC

83% bullish
                    of
                    266
                    ratings
Rate It


More Most Rated Stocks



























CLOSEX

Edit Favorites

Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.






Update

Clear List







CLOSEX
Customize your NASDAQ.com experience
Background Color Selector

Select the background color of your choice:





 Black
							





 Slate Gray
							






 Light Gray
							





 Gray Blue
							






Quote Search

Select a default target page for your quote search:



						 Real-Time

						 After Hours

						 Pre-Market
 News
					


						 Flash Quote

						 Summary Quote

						 Interactive Charts

						 Default Setting




					Please note that once you make your selection, it will apply to all future visits to NASDAQ.com.
					If, at any time, you are interested in reverting to our default settings, please select Default Setting above.
					
					If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com.
				





CLOSEX
Please confirm your selection:

					You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings?


YES
NO













CLOSEX


Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.





CLOSEX






































 SECGems: DP VIII Associates, L.P. 







































  







			Data feeds now available
			Excel / CSV / Java / Python /etc 
Database
Learn more









  




  


  






























 DP VIII Associates, L.P. 
		     










 Info




 Ownership




 Filings
21













	 
	
	 C/O DOMAIN ASSOCIATES, L.L.C.
	 
	  ONE PALMER SQUARE, SUITE 515
	
	   PRINCETON, 
	   NJ, 
	  
	
	  
		
		

			
			 
		
		
		
		 USA
		
	
	   609-683-5656    
	    

						        









Filing DateCurrent and former namesChanged on date




2009-06-10DP VIII Associates, L.P.








Central Index Key (CIK)
0001465143
State of Incorporation
DE
Country of Incorporation
USA










Ownership (Form 3,4,5)# Filings





 BLAIR JAMES C (0001024000) 


12




 DOVEY BRIAN H (0001207786) 


12




 Domain Partners VIII LP (0001465144) 


1




 Halak Brian K (0001354718) 


12




 SCHOEMAKER KATHLEEN K (0001207789) 


9




 TREU JESSE I (0001013425) 


12




 VITULLO NICOLE (0001196863) 


12











Form D Related Persons# Filings





 BRIAN H DOVEY (0001207786) 


1




 BRIAN K HALAK (0001354718) 


1




 JAMES C BLAIR (0001024000) 


1




 JESSE I TREU (0001013425) 


1




 KATHLEEN K SCHOEMAKER (0001207789) 


1




 NICOLE VITULLO (0001196863) 


1











All related persons/companies# Filings





 ACHILLION PHARMACEUTICALS INC (0001070336) 


1




 Atara Biotherapeutics, Inc. (0001604464) 


2




 BLAIR JAMES C (0001024000) 


12




 CALDEROME INC


2




 DOVEY BRIAN H (0001207786) 


12




 Dicerna Pharmaceuticals Inc (0001399529) 


3




 Domain Partners VIII, L.P. (0001465144) 


1




 Durata Therapeutics, Inc. (0001544116) 


3




 GLAUKOS Corp (0001192448) 


2




 Halak Brian K (0001354718) 


12




 Ocera Therapeutics, Inc. (0001274644) 


1




 Otonomy, Inc. (0001493566) 


2




 SCHOEMAKER KATHLEEN K (0001207789) 


9




 Syndax Pharmaceuticals Inc (0001395937) 


2




 TRANZYME INC


1




 TREU JESSE I (0001013425) 


12




 VERACYTE, INC. (0001384101) 


2




 VITULLO NICOLE (0001196863) 


12




 aTYR PHARMA INC (0001339970) 


2







 








db
 
 








































